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Vissa patientgrupper, t.ex. barn, behöver en mycket specifik dos av ett 
läkemedel för att nå en optimal terapeutiskt effekt. Därför behöver 
läkemedelsdosen i läkemedlet justeras specifikt för patienten. I den 
här avhandlingen undersöktes hur utskriftsteknologier kan användas 
i dosering av läkemedel och kombineras med lämpliga kvalitetskon-
trollsmetoder. Bläckstråleskrivarteknik erbjuder en lösning för att pro-
ducera sådana precisionsmediciner. Läkemedlet löses i ett lämpligt 
lösningsmedel och hälls i bläckpatronen i en skrivare. Därefter pro-
duceras läkemedlet genom tryckning på ätbara substrat eller filmer. 
Läkemedelsdosen kan justeras med hög noggrannhet och reproduc-
erbarhet på dessa tunna, stämpellika läkemedel som placeras i mun-
nen och löses upp snabbt.  Produktionshastigheten för dessa läkeme-
del är högt och tillverkningen behöver därför kombineras med snabba 
men pålitliga analysmetoder för kvalitetskontroll.
I optimala fall kunde denna småskaliga teknologi användas som en 
produktionslinje inom läkemdelsindustrin eller på apoteket där läkem-
edlet kunde tryckas direkt för patienten. Kvalitetskontrollmetoderna 
som undersöktes baserar sig bl.a. på spektroskopi och kolorimetri med 
vilka man mäter intensiteten av det reflekterade ljuset eller färgen från 
ytan av de utskrivna läkemedlen utan att röra provet. På så sätt förstör 
inte den använda metoden läkemedlet när den analyseras. Förändrin-
garna i ljus- och färgintensiteten kan relateras till läkemedelsmängden 
och dess fysikaliska egenskaper. I avhandlingen undersöktes fördelar-
na och nackdelarna av de olika analytiska metoderna. Arbete visar ty-
dligt att utskrifteknologier som används i kombination med lämpliga 
kvalitetskontrollsmetoder har stor potential att möjliggöra personalis-
erad dosering av läkemedel i framtiden.
A tailor-made dose suits you best.
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Abstract 
There is a need for development and production of pharmaceutical dosage forms 
with flexible dosing in order to achieve the essential requirements of precision 
medicine for patient-specific therapy. Precision medicine implicates a paradigm shift 
towards a new perspective both in clinical practice to include patients’ individual 
characteristics in a more personalized diagnosis of the disease and subsequently in 
formulation design and manufacturing of the tailored dosage forms for an optimal 
and well-tolerated therapeutic treatment.  
From the drug delivery perspective, adoption of new technologies that provide 
dose flexibility in small batch productions has been regarded as key for on-demand 
production of tailored medicines for late-stage delivery at envisaged point-of-care 
such as in hospitals or pharmacy settings. In this regard, inkjet printing technology 
has been proposed in the past decade as the method that is capable of depositing 
extremely accurate, low and uniform amounts of drugs on various edible polymeric 
films which is currently being further investigated by researchers. Today, the state of 
the art inkjet printers with compact design, open architecture and advanced 
integrated visualization systems provide thorough control over the shape, size, 
alignment and spatial deposition of thousands of single drops in picoliter range in 
pixel-wise accuracy onto the printing substrates. Printed pharmaceuticals are often 
in the form of orodispersible formulations that rapidly dissolve in the mouth 
resulting in ease of administration and higher patient compliance especially for 
pediatrics and those with swallowing inabilities and disorder. In this way, when the 
drug is properly absorbed through the oral mucosa, it avoids first-pass metabolism 
in the liver and directly enters the systemic circulation and starts a fast onset of 
actions.  
One of the main problems in the way of inkjet printing technology becoming a 
genuine, viable and commonly accepted method by regulatory agencies for 
continuous manufacturing of solid dosage forms is the lack of rapid, robust, reliable 
and most importantly non-invasive analytical techniques for real-time quality 
control of the printed formulations. This thesis was mainly focused on exploring a 
variety of analytical techniques and small-size instrumentations for the study of drug 
content, uniformity of drug distribution and drug release profile from the printed 
units.  
Ion-selective electrodes were designed for continuous monitoring of the drug 
release from porous cellulose substrates and thin films as an attempt to propose a 
cost-effective and efficient alternative to conventional time and labor-intensive 
methods. Flexographic printing technique was used for applying several layers of 
highly viscous and insoluble polymeric coating on already inkjet printed 
formulations to achieve formulations with modified release profiles. Near-infrared 
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(NIR) hyperspectral imaging was applied to predict the drug amount and to create 
concentration distribution maps that offer both statistical and visual assessments of 
the printed formulations. The feasibility of a compact colorimetric device was 
investigated in CIELAB color space for indirect estimation of the drug content in 
pediatric orodispersible formulations. Finally, a handheld NIR spectrometer was 
used together with advanced chemometrics to build predictive models for drug 
content analysis and classification of the dosage forms containing two poorly water 
soluble drugs. In addition, the application of multivariate data analysis techniques 
for processing and modeling of the spectroscopic data were discussed in detail. 
Several other analytical techniques were also applied to study the surface 
morphology, surface roughness, texture, mechanical properties and disintegration 
behavior of the raw and printed substrates together with solid-state characteristics 
and the stability of the inks and the drugs in formulations. The advantages and 
shortcomings of each formulation design and applied analytical method were 
highlighted and a general approach for future complimentary studies was proposed.  
This research provides a deeper insight into the inkjet printing process of drug 
formulations and subsequently inspects the feasibility of the proposed analytical 
probes as fast, reliable and non-invasive quality control tools at the production line 
in search for bringing the concept of personalized medicine closer to reality.  
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1. Introduction 
‘Drug delivery’ refers to approaches and tactics to encapsulate an active 
pharmaceutical ingredient (API), which is the drug compound, into a ‘dosage form’ 
which is the final pharmaceutical product that is administrated to a human or 
animal body through various routes. Many considerations are made in order to 
achieve a desired therapeutic effect in a balance with minimized side effects of drug 
consumption.  
The route of administration and the nature of the delivery system dictate the 
patient compliance and adherence to the medical treatment. Oral route is the most 
common and convenient route for drug delivery. However, a great number of 
patients have experienced difficulties regarding swallowing large solid dosage forms 
(SDFs) such as tablets and capsules. Such conventional dosage forms are produced 
in large batch productions during many tedious steps and finally come only in a few 
fixed doses to the market. In order to reach the desired flexible dose, a tablet needs to 
be divided into pieces, which in turn is prone to more dose variations and damage to 
the integrity of the dosage form which was carefully formulated for a specific 
delivery purpose. In addition, many drugs when taken orally are metabolized 
extensively when exposed to the gastrointestinal tract (GIT) and mostly in the liver 
so that usually a greater dose than needed should be administered which can be 
harmful.  
On the other hand, about 40% of current market approved drugs and nearly 90% 
of all new molecular entities (NME) are reported to be poorly water soluble. Such 
drugs have an aqueous solubility of less than 100 μg/ml and depending on their lipid 
permeability or lipophilic characterization, they belong to the class II or class IV of 
the Biopharmaceutics Classification System (BCS). From the drug delivery 
standpoint, the main challenge of modern pharmaceutical industry is to formulate 
such drugs into various dosage forms through different strategies in order to 
enhance the water solubility, the dissolution rate and subsequently bioavailability of 
the formulations. Moreover, there are many highly potent drugs with narrow 
therapeutic index (NTI) that require careful dose adjustment to avoid severe adverse 
effects of possible over dosing and the lack of therapeutic effects in case of under 
dosing. In addition, the required dose for specific patient populations such as 
pediatrics depends on patient’s weight which is subjected to variation. The delivery 
challenges become even greater when not only very low and uniform doses of such 
drugs need to be present in the formulations, but also the allowance for dose 
flexibility needs to be considered as well.  
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Considering all the factors above, the application of inkjet printing technology 
has been studied as an innovative approach for design and delivery of new 
formulations with precise dosing flexibility of many poorly water soluble and narrow 
therapeutic index drugs in small and cost-effective batch productions. The printed 
formulations are typically easier to manufacture since there are many fewer steps in 
the production line. Such dosage forms optimally offer higher compliance when 
taken orally with discreet administration, fast disintegration in the mouth without 
the need to drink water and the opportunity to introduce the drug directly to the 
systemic circulation. 
Due to the novelty of inkjet printing technique in the pharmaceutical field and 
restrictive regulatory conditions, no definitive approaches have been established and 
implemented to date for inkjet printing in the guidelines to define Good 
Manufacturing Practice (GMP) requirements or outline Process Analytical 
Technology (PAT) tools to ensure Quality by Design (QbD) principle for printing 
delivery systems. Similarly, the application of proper analytical techniques for 
quality control of such newly designed products needs to be recognized and 
regulated as well. Current established analytical methods such as ultraviolet-visible 
(UV-Vis) spectroscopy, High performance liquid chromatography (HPLC) and 
mass spectroscopy apart from their bulky, complicated and expensive machinery 
that require intensive labor and maintenance face other restrictions especially in case 
of a fast work flow and costly samples which need to be pretreated and destroyed 
when analyzed during a lengthy procedure. 
For clear reasons, it was envisioned that application of reliable, small-scale and 
non-intrusive analytical tools for automated on-, at and in-line monitoring and 
quality assessment of the final printed products would be a timely approach for the 
missing puzzle in promotion of inkjet printing technology as a continuous method 
for official adoption and authorization in pharmaceutical industries and 
pharmaceutical manufacturing in general. Therefore, efforts have been made in this 
thesis to explore the applicability of a number of analytical tools to gain a deeper 
understanding about their advantages and limitations for quality control of printed 
formulations to pave the way for inkjet printing to become authorized as the 
forefront of manufacturing and delivery of new medicines for ultimate goal of 
individualized therapy. 
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2. Literature overview 
2.1. Personalized/precision medicine 
Clinicians have been observing since ancient times that patients with similar 
symptoms may suffer from different illnesses initiated by different causes. Today, the 
medical care and treatment approaches towards such apparently similar symptoms 
should be tailored to take into account the individual characteristics of the patients 
that may have caused the disease. In this way, the therapeutic outcome would be 
more efficient and beneficial for all the patients’ populations regardless of their vast 
differences in physiological conditions. 
The general approach of ‘one-size-fits-all’ as the ‘standard of care’ based on the 
common clinical indications has been practiced commonly in the manufacturing of 
pharmaceutical products for the treatment of the ‘average patient’. The therapeutic 
approach of ‘personalized medicine’ or ‘precision medicine’ has been developed to 
address the shortcomings of the traditional model and to transform the paradigm of 
medicinal practice by allowing a patient’s individual information to play its crucial 
role in the search for optimal course of medical treatment. For this to become reality, 
the pharmaceutical industry should adapt accordingly in order to find practical 
solutions for design and development of patient-specific formulations in small-scale 
production settings. 
The term personalized medicine was first published by Langreth and Waldholz 
(1999) in The Wall Street Journal even though some of the underlying concepts 
could be traced back to the early 1960s (Jain, 2002). In the new millennium, the 
worldwide research interest on the topic has been increasing considerably which is 
reflected in the number of articles published related to the terms ‘personalized 
medicine’ and ‘precision medicine’ in PubMed library of medicine (Figure 1).  
 
Figure 1. The number of publications per year in the new millennium related to the 
terms “personalized medicine” and ‘Precision Medicine’. Data were obtained on a 
PubMed search in March 2017. 
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It is necessary to understand that ‘personalized medicine’ does not refer to 
unique treatments for each individual as the term might suggest, but rather 
optimization of pharmaceutical treatment and future illness preventions based on 
patient characteristics such as genetic and genomic differences, age, gender, race, 
metabolic capacity, anatomical and physiological features, history of prior 
treatments, environmental factors, lifestyles, etc. In the European Union, 
personalized medicine is described as ‘providing the right treatment to the right 
patient, at the right dose at the right time’. The National Research Council (NRC) 
favors the term ‘precision medicine’ over ‘personalized medicine’; however, both 
terms are used interchangeably today.  
The Human Genome Project (HGP) was reported to have successfully completed 
the mapping of the human genome in 2003 discovering that the great variation in 
the human species when exposed to a disease was related to only 0.9% inter-
individual genetic differences while 99.1% of the genetic make-up of humans was 
identical (Novelli, 2010). Genetic and genomic differences could affect the individual 
responses to specific drug therapies and regulate the minimum effective 
concentration (MEC) and minimum toxic concentration (MTC) of a drug; therefore, 
playing an important role in the rate of drug absorption, distribution and 
elimination in the body (Mallal et al., 2002; Wesołowska-Andersen).  
However, this thesis is not focused on pharmacogenomics and genetic variations 
in metabolic pathways of patients, but it is rather dedicated to exploring flexible 
dosing opportunities in enhanced delivery systems given the needs of precision 
medicine for different patient populations, e.g. infants, children, adolescents, the 
elderly. The importance and necessity of personalized medicine for successful age–
appropriate therapy has been discussed extensively in the literature (Breitkreutz and 
Boos, 2007; Visser et al., 2017). The therapeutic dose for pediatric patients is usually 
calculated based on the weight or body volume of the child which is subjected to 
variation; therefore, a wider selection of dose strengths should be available for 
successful therapeutic outcomes. The prospect of achieving flexible dosing to fit the 
criteria of precision medicines is limited and highly challenging for most commonly 
produced oral SDFs such as tablets and capsules. This is mostly due to the very 
nature of such dosage forms and several processing factors involved during their 
large batch manufacturing processes. For this matter, liquids/suspensions have been 
considered more appropriate dosage forms for children from birth to 8 years old 
since they offer easier dose flexibility while eliminating undesired swallowing 
necessity of usual SDFs that many patients suffer from (EMA, 2006). However, 
liquid medicines face problems of their own such as precise adjustment of the 
correct dose, stability of the drug in the formulation, multiple administrations 
during the day for the lack of controlled-release profiles, not to mention the high 
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costs of handling, transportation and storage conditions of such bulky dosage forms. 
Moreover, the acceptability and palatability of the liquid dosage forms are lower 
than SDFs due to their usual bitter taste especially for children who have more 
distinct preferences for sweet tastes (Tanner et al., 2014). Altogether such negative 
factors related to liquid dosage forms make this option impractical as a concluding 
solution in pursuit of a universally accepted form of delivering flexible dosed 
formulations. 
The only available option in the past to obtain the appropriate dose for a specific 
treatment was to split commercially available tablets and other solid dosage forms 
that come with fixed and limited API doses to the market (Rosenberg et al., 2002; 
Teng et al., 2002). However, even applying appropriate tablet splitting tools and 
procedures may compromise the accuracy of the final dose, the quality and integrity 
of the pre-designed dosage unit and the possibility of drug wastage. Shah et al. 
(2010) have expressed numerous potential concerns of such practice, including 
uneven drug content and the stability concerns of the drug in the remaining sections 
of the medicine. McDevitt et al. (1998) discovered that out of 1752 manually split 
tablets, a staggering 41.3% showed more than 10% deviation from the ideal weight 
while 12.4% had more than 20% deviation. Such undesirable variations may have 
devastating effects on a patient’s health especially in case of drugs with a narrow 
therapeutic index (NTI) as well as heart and thyroid medicines in which the risk of 
under-dosing or over-dosing is more critical. The proper dose adjustment of such 
drugs becomes even more essential for patients who suffer from chronic diseases 
with persistent effects that require long-lasting medications.  
It is worth mentioning that a new technology for tablet manufacturing was 
patented claiming to offer splitting options while providing consistent partial doses 
(Solomon and Kaplan, 2007). Also Laukamp et al. (2014) formulated a delivery 
method called ‘solid dosage pen’ involving carbamazepine loaded rods that were 
produced by hot-melt extrusion in which the dose flexibility could be achieved by 
slicing tablet-like pieces. However, naturally such claims, even when successfully 
accomplished, are limited to attain only a few doses from a larger unit and cannot 
possibly offer a convenient and practical range of dose flexibility. 
In addition, regarding administration, studies have shown that patients with 
swallowing disorder, mental illness and dysphagia are amongst those who had 
suffered the most when consuming large oral dosage forms (Dixit and Puthli, 2009; 
Nilausen et al., 2011). There have been a number of publications stating that in 
general between 20% and up to 50% of all drug consumers experience swallowing 
discomfort when taking available SDFs (Brniak et al., 2015; Lau et al., 2015). 
McDevitt et al. (1998) additionally claimed that about 96.8% of the patients 
preferred commercially available lower dosed formulations while 77.2% were willing 
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to pay more for such products. To look more closely into the issue, Schiele et al. 
(2013) published a thorough study stating that out of 1051 participants, around 
37.4% (N = 393) had faced swallowing difficulties regarding solid drugs in which 
younger and female patients were affected significantly more. The reasons for such 
difficulties were related to the size (74.6%), surface (70.5%), shape (43.5%), and 
flavor (22.1%) of the dosage forms.  
Altogether, the abovementioned difficulties give rise to patient dissatisfaction 
and poor adherence to the treatment procedures. In this regard, the introduction of 
the precision medicine has fundamentally changed the medical practice to bring 
much-needed tailor-made medicinal products closer to reality with innovative 
delivery systems. The announcement of the Precision Medicine Initiative  (PMI) in 
2015 had a clear message that precision medicine had gained a universal momentum 
in its progress (The White House, 2015). According to researchers of Tufts center for 
the study of drug development (CSDD) in 2015, the United States Food and Drug 
Administration (FDA) had approved 137 drugs with pharmacogenomics 
information in their labeling in which 20% of all FDA approvals in year 2014 alone 
had belonged to the personalized medicines category (Tufts, 2015). Tufts (CSDD) 
press release further stated that biopharmaceutical companies were expected a 33% 
rise in investment on personalized medicine followed by 69% increase in medicines 
in development by 2020. 
According to the FDA, ‘the goal of personalized medicine is to streamline clinical 
decision making by distinguishing in advance those patients most likely to benefit 
from a given treatment from those who will incur cost and suffer side effects without 
gaining benefit’. Today, the worldwide wireless and computational advancements 
have paved the way for a more effective medical treatment and individual care 
including continuous monitoring of patients’ response and health condition 
regarding their medication (FDA, 2013). The rapidly growing field of personalized 
medicine is the cornerstone in future research and development in the field of 
pharmaceutical sciences. Personalized medicine highlights a real medical need for 
the individuals to receive a customized treatment with a deeper understanding of 
their individual characteristics that governs the pharmacokinetics of the drug in 
their body. Furthermore, this concept aims to guarantee higher patient compliance 
and safety profile of the drug and the excipients which together will certainly result 
in a more successful therapeutic outcome. 
2.2. Orodispersible films  
‘Orodispersible film’ (ODF) is the preferred term for the European Medicines 
Agency (EMA) to describe thin, flexible, planar and stamp-sized polymeric films 
that are designed as single or multi-layer systems to be disintegrated rapidly when 
placed onto the saliva-wetted tongue without the need for drinking additional water 
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(Hoffmann et al., 2011). Such properties have made ODFs a promising approach for 
drug delivery with improved compliance and more convenient administration 
generally for pediatrics, geriatrics, psychiatrics and unconscious patients as well as 
those with Parkinson’s disease, vomiting, swallowing disorder and dysphagia (Irfan 
et al., 2016). One of the most important advantages of such formulations is that 
when the drug is properly absorbed through the oral mucosa, it avoids the first-pass 
metabolism and enters directly into the blood stream resulting in greater 
bioavailability with an immediate onset of actions and pharmacological 
effects (Clarke et al., 2003; Zhang et al., 2002). Due to the novelty of this delivery 
method, ODFs have not been listed in any pharmacopeia yet. Therefore, there is a 
need for an official monograph to regulate their standard production, test 
procedures and analysis techniques (Preis, 2014). To be specific, so far no standard 
disintegration test with a definitive end point has been established for ODFs. This 
has led researchers to improvise and design different experiments that can be found 
in many recent publications (Garsuch and Breitkreutz, 2010; Low et al., 2015; Preis 
et al., 2014; Woertz et al., 2011). According to a published monograph (European 
Pharmacopoeia Commission, 2008) a 180s time interval was defined as the limit for 
disintegration of the orodispersible tablets. The 180s time interval is still used today 
also for disintegration time limit of the ODFs. 
2.2.1. Manufacturing of orodispersible films 
The first ODF in the market was introduced in 2001 by Pfizer as thin strips of 
breath-freshener Listerine® PocketPaks followed by the first over-the-counter (OTC) 
ODF containing an API (benzocaine) that was launched by InnoZen  in 2003. Later, 
in 2010, the first prescribed ODF containing risperidone was made commercially 
available in the market (Hoffmann et al., 2011). In 2013, it was reported that most of 
the available ODFs were produced by the solvent casting technique (Genina et al., 
2013b). The rest of ODFs are produced either by electrostatic spinning method or 
by hot melt extrusion method for modified release purposes (Palo, 2017).  
In the solvent casting method, a powder mix of the drug, the film forming 
polymers, plasticizers and other excipients, if needed, is dissolved in aqueous or 
organic solvents and continuously stirred for a few hours. Later the obtained 
homogeneous viscous coating mass is uniformly spread out on top of an inert 
surface and is leveled to the desired thickness using a coating knife. The solvent is 
then allowed to dry so that a thin dry film remains. One substantial advantage of this 
approach is the manufacturing of the entire product using only one production line 
in which the dose adjustment is possible by simply cropping a certain size of the film 
(Preis, 2014). The great versatility of polymer-based orodispersible dosage forms has 
established their role as an appropriate and promising delivery platform for the 
demanding market (Borges et al., 2015).   
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However, regardless of the apparent simplicity of the solvent casting method in 
theory, it faces in reality potential challenges to guarantee a uniform thickness and 
the drug content uniformity in big scales where cropping a selective area may pose 
dose inaccuracy (Janssen et al., 2013).  
Printing APIs onto placebo orodispersible films has been reported to be a smart 
solution to achieve dose precision for population-specific drug delivery systems 
which proposes yet another bid for application of the emerging inkjet printing for 
manufacturing of pharmaceutical products (Planchette et al., 2016; Scarpa et al., 
2017). Janssen et al. (2013) have successfully printed low doses of rasagiline mesylate 
and tadalafil as the model drugs on placebo ODF carriers by the flexographic 
method in industrial scale and have compared the results with the common solvent 
casting technique. Usually the drug-free films are casted on top of an intermediate 
casting liner/surface (e.g. PET films) which is kept attached to the film to facilitate a 
flat and level printing job without rolling up, waviness or ripple effect on the film’s 
surface during and after the printing procedure (Genina et al., 2013b).  
2.2.2. Challenges and shortcomings  
ODFs need to have a fast disintegration time while having a certain mechanical 
stability to ensure a robust and practical manufacturing and packaging for easier 
handling, storage and administration (Peh and Wong, 1999). The challenge is to 
fulfill such requirements considering the fact that there is an inverse relationship 
between stronger mechanical properties and the disintegration time of a thin film. 
However, a very fast disintegration time is not optimal since there may not be 
enough time for proper drug absorption in the mouth. Acceptable bioavailability 
and safety of the excipients for pediatrics and especially neonates and infants with 
enzymatic immaturity can further complicate the choice of the excipients for such 
patients (Breitkreutz and Boos, 2007). In addition, due to the nature of this delivery 
system, the drug load is limited. Therefore, the application of ODFs is mostly 
restricted to low doses of highly potent drugs (Hoffmann et al., 2011). Most 
importantly, since the APIs dissolve in the saliva, pleasant taste and organoleptic 
properties would play a major role in palatability and compliance particularly for 
pediatric patients. Taste masking methods could further limit the drug load and in 
case of extremely bitter APIs it could even be impossible to accomplish. The taste 
attributes of the ODFs remain the main drawback for this delivery system to date 
which is discussed extensively by Preis (2014) and Walsh et al. (2014). 
2.3. Inkjet printing technology 
The need for ever-growing customized products has persuaded pharmaceutical 
companies of all magnitudes to consider a shift from the paradigm of large-scale 
batch production, which is both highly labor and capital-intensive, towards more 
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decentralized small-scale manufacturing strategies. The small-batch production of 
patient-specific pharmaceutical products in a continuous process design is the 
defining strategy that can keep the companies at the forefront of the business 
competition in an emerging era of personalized medicine.  
The advancement in design, robustness and flexibility of non-contact industrial 
inkjet printers along with the diversity and simplicity in digital design of the 
formulations can make way for a paradigm shift in pharmaceutical manufacturing 
processes (Melendez et al., 2008; Scoutaris et al., 2016). The research and 
development related to applications of inkjet printing technology as a low-cost, eco-
friendly, compact and highly reliable method for small batch production of oral 
SDFs have been substantially increasing during the past decade (Buanz et al., 2011; 
Janssen et al., 2013; Sandler et al., 2011).  
Inkjet printing includes a wide range of high speed technologies that are capable 
of direct deposition of thousands of droplets onto specifically defined locations on 
various porous substrates through microscopic nozzles in a digitally-controlled 
environment. In this regard, inkjet printing technology can be implemented for 
rapid manufacturing of extremely uniform, precise and low doses of a variety of 
drugs, with more focus on poorly water soluble and narrow therapeutic index drugs, 
in single or multi-drug delivery system for personalized therapy (Alomari et al., 
2015; Preis et al., 2015; Raijada et al., 2013). Hirshfield et al. (2014) used inkjet 
printing technology to construct a small scale, automated and controlled 
manufacturing method called dropwise additive manufacturing of pharmaceutical 
products (DAMPP) for deposition of both the API and the polymer excipient 
directly onto edible substrates. In this sense, DAMPP could provide a practical 
alternative to traditional large-scale batch manufacturing processes with their many 
limitations in terms of process control and automation. 
Inkjet printing technology also provides delivery solutions for large and complex 
biological drugs such as peptides and proteins (Montenegro-Nicolini et al., 2017). 
The formulation of biological drugs usually faces more difficulties due to their large 
molecular size, selection of appropriate excipient, poor membrane permeability and 
instability in enzymatic solutions (Kolakovic, 2013a). Such drugs are also prone to 
first-pass metabolism and require specific and targeted delivery in small doses (Ross 
et al., 2015). In addition, nanosuspensions containing poorly water soluble drugs in 
the form of conventional crystalline nanodrugs together with stabilizing emulsifying 
agents or in the form of ‘amorphous drug nanoplex’ have also been printed for 
personalized therapy (Cheow et al., 2015; Pardeike et al., 2011). The technology 
further offers opportunities to produce oral and non-oral (topical, implants, etc.) 
drug formulations mostly for immediate release (Palo et al., 2017) and less 
considerably for modified release purposes (Gu et al., 2012; Preis et al., 2015; Uddin 
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et al., 2015). The controlled-release formulations can be prepared either by direct 
printing of the drug-polymer ink solution or by polymer coating of already inkjet 
printed formulations containing the API (Genina et al., 2012; Scoutaris et al., 2011). 
The rate of the drug release can also be controlled by selecting different carrier 
geometry patterns as crucial design parameters affecting the interaction of the 
delivery system with the tissues mainly due to the changes in the surface area (Lee et 
al., 2012).  
In conclusion, from the industrial point of view, inkjet printing further offers an 
inherently scalable and continuous process with high reproducibility, improvement 
in product quality and minimal waste and contamination. Additionally, the 
potential to eliminate many middle steps of the conventional solid dosage 
production and a subsequent drastic reduction in the energy consumption, further 
help to optimize the cost and efficacy of the drug delivery systems that are produced 
by inkjet printing technology.  
2.3.1. Inkjet printing classifications 
Inkjet technology is classified into two categories, namely continuous inkjet (CIJ) 
printing and drop-on-demand (DoD) printing that are distinguished by the physical 
process that is involved in generation of  the droplets (Derby, 2010). The underlying 
principle in CIJ printing is breaking up a continuous stream of fluid into droplets at 
regular intervals by perturbation. A portion of the generated droplets are then 
deflected after leaving the nozzle according to the print pattern either by high 
voltage electrical fields, airflow or sometimes thermal steering. This portion of the 
droplets continue their flight path onto the surface of the substrate at angles 
proportional to the degree of deflection while the undeflected portion is collected by 
a gutter and fed-back into the ink circulation system. Such printing principle makes 
CIJ printing a high-speed process. However, the print resolution is compromised.  
On the other hand, in the DoD method the droplets are formed impulsively and 
are ejected only when required. The activating signal is usually an electric signal that 
is applied close to the orifice cavities of the nozzles. DoD printing has been utilized 
more widely in pharmaceutical research applications since it offers more control 
over the deposition of the droplets and the fact that only small volumes of ink 
solutions are required for the printing job as opposed to a large recirculating volume 
that is needed for CIJ printing.  
2.3.2. Thermal and piezoelectric inkjet printing 
Drop-on-demand technologies are mainly divided into two categories of thermal 
inkjet printing and piezoelectric inkjet printing according to the technique that is 
employed to eject the droplets. The sophisticated and immaculate design of the 
thermal inkjet printing technology is found in every day consumer desktop printers 
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which are quite affordable and readily available. In thermal inkjet printing the image 
signal is transmitted by a highly accurate electric current network of up to 400 
miniaturized elements, each in contact with the ink next to a nozzle on the silicon 
printhead. According to the digital print signal, a pulsed supply of electric charge 
heats up the elements to up to 300 ˚C for a very short period of 2 to 10 μs (Hölzl et 
al., 2016; Melendez et al., 2008). The rapid rise of temperature causes localized 
evaporation of the ink followed by formation of an ink bubble. The expanding 
bubble forces a drop out of the nozzle orifice. When the signal ends, the bubble 
collapses and the resulting negative pressure fires the drop out while a new drop is 
simultaneously replaced into the nozzle chamber. The drops in the volume range of 
2-180 pl are usually ejected in the frequency range of 5 to 10 kHz out of hundreds of 
nozzles in the diameter range of 10-50 μm and reaching the speed of up to 10 m/s 
(Melendez et al., 2008). The spatial location of the landing droplets is also digitally 
controlled by a motor which is highly aligned with the image signal in pixel-level 
precision (Kolakovic, 2013b; Le, 1998). 
In piezoelectric inkjet printing, the image signal is produced by voltage tuning of 
a piezo-element in contact with the ink. The piezoelectric element that produces a 
deformation mode causes a pressure wave which regulates the flow of the drops out 
of the nozzles by mechanical displacement (Le, 1998). A wider variety of liquids with 
higher drop frequency can be printed by piezoelectric technique as compared to 
thermal inkjet printing while the application of relatively cheaper thermal inkjet 
printers is limited to mainly aqueous solutions with suitable vaporizing properties 
(Kolakovic, 2013b). 
Modified consumer desktop thermal inkjet printers (Buanz et al., 2011; Genina et 
al., 2013b) and Dimatix Materials piezoelectric inkjet Printers (Genina et al., 2013a) 
have been used more frequently due to their high availability and reliable 
performance, in addition to low-cost and compact design with disposable ink tanks. 
Such characteristics make these printers great candidates to be used in a pharmacy 
or hospital settings for late-stage tailored delivery systems. Planchette et al. (2016) 
used both piezoelectric and solenoid valve-based inkjet printing techniques, that 
adjusts the nozzle opening by the electromagnetic force from an energized solenoid 
coil, to print two different inks solutions on various medical-grade oral films. In 
addition, they successfully coated a non-porous substrate with a hydrophilic 
polymer in polyethylene glycol (PEG) prior to printing to homogenously distribute 
the poorly water soluble API on the coating layer and to avoid crystallization of the 
drug in addition to taste-masking purposes. Finally, in a classic and thorough study 
by Wickstrom et al. (2015) piezoelectric inkjet printed systems containing poorly 
water soluble drug indomethacin with flexible doses was produced on porous 
substrates. They further studied the solid-state properties of the formulations, the 
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printability of various inks regarding their rheological properties, the influence of 
the excipients and finally the improvements in the dissolution rate of the 
amorphous API in the printed formulations. 
2.3.2.1. Printing parameters for piezoelectric inkjet printing 
Careful adjustment and optimization of printing parameters and particle size in a 
specific ink solution further guarantees a continuous and uniform automated 
printing job. The main parameter for a piezoelectric inkjet printer is an electric 
waveform consisting of the voltage and the pulse shape that is applied to the 
piezoelectric element. The electric waveform dictates the shape, size and proper 
formation of ejected droplets and in short, the printability of the ink (Mogalicherla 
et al., 2014). McKinley and Renardy (2011) discussed extensively about printability 
of ink formulations based on two major parameters of viscosity and surface tension 
along with the density of the ink that altogether influence the dimensionless Z-value 
as the criterion for printability. Hutchings and Martin (2012) specified a typical 
viscosity range from 1 to 20 mPa.s and a surface tension range from 25 to 60 mN/m 
for available inkjet printers. However, such specifications are not absolute and have 
also been reported with variations such as 2-30 mPa.s and 25-50 mN/m (Daly et al., 
2015). Similarly, a Z-value in the range of 1 to 14 has been reported to be optimal for 
printing (Derby, 2010). In order to avoid clogging of the nozzles and guarantee a 
smooth and continuous printing job, the particle size of the drug in the ink solution 
should also be taken into account according to the nozzle diameter. For a printable 
ink containing API particles, volume distribution value (dv90), which is the value 
that 90% of the particles have smaller diameter than this value, should be less than 
2% of the nozzle diameter (Kuscer et al., 2012).  
2.3.3. Flexographic inkjet printing  
Apart from the classic inkjet printing techniques, there is also flexographic printing 
which is a modern version of letterpress printing method with the possibility to print 
a diverse range of aqueous, polymer-based solutions and nanosuspensions onto a 
large variety of flexible substrates and surfaces (e.g. plastic, foil, paper, etc.). Inks 
with viscosity range from 50 to 500 mPa.s and surface tension between 25 and 45 
mN/m can normally be printed using the flexographic method (Ihalainen et al., 
2015).  In this sense, the flexographic method provides certain possibilities for 
printing high molecular weight species such as proteins and biomolecules in highly 
concentrated inks. Flexographic printing can also be used to print highly viscous 
polymeric solutions for coating purposes to achieve modified release profiles or taste 
masking with or without the inclusion of the API. However, the printing resolution 
and the control over spatial deposition of the ink are compromised. Thus, the 
pharmaceutical application of this printing method has not been yet intensely 
investigated. 
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Flexographic printing is a rotary printing process in roll-to-roll fashion that is 
used primarily for packaging and labeling of products. In this method, a rotating 
‘fountain cylinder’ in contact with the ink tray picks up the ink and transfers it to the 
‘anilox cylinder’ which has cell patterns on its surface. The ink on the anilox cylinder 
is leveled with a doctor blade, so that a certain and uniform amount of ink is fed 
onto the ‘plate cylinder’ that has raised (relief) patterns attached on its outer surface 
as the image to be printed. This raised pattern is usually made of a low-cost flexible 
polymer which is simply attached around the plate cylinder by two-way adhesive 
tape. Finally, an ‘impression cylinder’ is used to apply a force, usually between 50 to 
200 N, to the ink covered relief pattern plate with the substrate sandwiched in 
between, so that the pattern is imprinted onto the substrate.  
2.4. Analytical methods for quality control of printed medicine  
It is understood that quality control of the pharmaceutical products has the utmost 
importance in regards to the safety, the integrity of the dose and the overall 
therapeutic effects of the medicinal products. Quality control methods also provide 
information regarding the degradation process of the drug in formulation that 
ultimately defines the shelf life of the product.  
Process analytical technology (PAT) is defined as a system to design, analyze and 
control pharmaceutical manufacturing processes through well-timed measurements 
of Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) of raw 
and in-process materials as part of a Quality by Design (QbD) approach to guarantee 
the desired final quality of the products. In 2004, FDA initiated PAT as a guidance to 
encourage and promote voluntary adoption of innovative manufacturing 
technologies to improve the quality assurance and the efficacy of the drug 
development (FDA, 2004). This non-binding regulatory framework aimed to gain 
deeper insights into the factors that influence the production process parameters, 
particularly in technologically complex procedures that oblige more strict protocols 
(Korasa et al., 2016). 
In this regard, it was envisioned that at/in/on-line integration of miniaturized 
and non-invasive measuring probes together with the application of concrete data 
analysis tools, if needed, could provide greater control over the state of the 
pharmaceutical materials and processes during the production.  
FDA also have allowed continuous processing of pharmaceutical products 
according to the QbD principle in which in-depth control of raw materials and 
process parameters ensures the high quality manufacturing of the final products 
(Linden, 2012). FDA underlined that the quality must be built into the product by 
designing a robust formulation and manufacturing procedures rather than increased 
testing of products and processes (Yu et al., 2014). The industrial inkjet printers that 
are already available in the market provide high accuracy and quality of the printing 
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process. Therefore, the QbD principle of the printed products that are manufactured 
by such printers can be fulfilled by careful selection of the ink solution with specific 
rheological properties together with smart combination of the API and medical 
grade carrier substrates that are suitable for the printer in use. The final quality of 
the inkjet printed formulation is highly dependent on the precision of the 
engineering design of the employed machinery, printability of the ink solution and 
the physicochemical properties of the API both in the liquid state in the ink solution 
before and during printing and the solid-state within the substrate matrices after 
printing.  
The main problem in the way of inkjet printing technology becoming a genuine 
and viable method for continuous manufacturing of solid dosage forms is the lack 
of rapid, robust, reliable and non-destructive analytical techniques for real-time 
quality control of the printed formulations (Edinger et al., 2017). The necessity of 
the alternative quality control devices for printed formulations which was addressed 
earlier by Raijada et al. (2013), still stands today.  
This research was mainly focused on the feasibility of various quality control 
methods to monitor the drug content and the drug release from the printed 
formulations. Such quality control techniques offer a significant reduction in 
procedure time of the conventional quality control methods which are lengthily, 
tedious and labor-intensive. In this regard, this thesis aims to provide the necessary 
initials to make way for the much-needed shift in the quality control approaches 
towards more improved and possibly automated analytical techniques in search of 
making inkjet printing a viable, realistic and continuous process of manufacturing 
orodispersible formulations for personalized therapy.  
For this purpose, the application of potentiometry, hyperspectral NIR imaging, 
colorimetry and NIR spectroscopy was proposed to create a platform for fast, easy to 
use, reliable and non-invasive alternative analytical techniques for inkjet printed 
formulations. The compact and robust design of the small-scale probes such as the 
ion-selective electrodes (ISEs) as well as the non-invasive nature of the handheld 
colorimeter and the NIR spectroscopic device offer an indispensable factor for 
in/on-line adoption in the production line at the envisaged point of care. In addition, 
the fast and non-intrusive NIR hyperspectral imaging technique that is designed for 
integration in the continuous processes further allows in-process monitoring of the 
uniformity of the API distribution and the overall consistency of the final products. 
The application of such advanced process control methods, when properly 
determined by the regulatory authorities, will provide alternative means for a closer 
monitoring of the quality aspects of the printed formulations in real time. 
A summary of the literature review on the employed analytical techniques is 
presented below. 
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2.4.1 Potentiometry 
Potentiometry is a well-known analytical technique with a long history in measuring 
the electrical potential difference or electromotive force (EMF) between a reference 
and a working/indicating sensor in a sample solution. Ion-selective electrodes (ISEs) 
are the most frequently used electrochemical sensors that facilitate the conditions for 
an ionic exchange process in which the potential build-up at the boundary of the 
membrane/solution can be measured and correlated to the concentration of the 
target ion in the solution. ISEs respond selectively by design to a particular 
electroactive species in a solution. Such sensors are capable of correlating the electric 
signals to the chemical information and vice versa by means of a conditioned 
membrane that is connected to an ion-to-electron transducer. The generated 
boundary potential is measured against the potential of a stable reference electrode 
and it can be used for quantitative analysis of the target ion in real time. Nernst 
equation correlates the electrical potential difference between the two electrodes to 
the activity of the ion that initiates such phenomenon: 
ΔE = ோ்ɀி  ln (αm/αi) (aq),                         (1) 
where ΔE is the potential difference measured between the working and the 
reference electrodes (V), R is the universal gas constant (8.314 J/mol. K), T is the 
absolute temperature in (K), ɀ is an integer representing the charge of the target ion, 
F is faraday constant (96,485.3 C/mol), αm is the activity of the target ion in the 
membrane and αi is the activity of the target ion in the analyte solution. Necessary 
assumptions are made in order to make a simpler and more practical version of 
equation (1). For example, the negligible potential change in the reference electrode 
is ignored and the activity of the target ion is replaced by its concentration assuming 
an ideal case of a clear dilute solution. Therefore, substitution of the constant values 
into equation (1) results in: 
         ΔE (mV) = 59.2/ɀ log (Cm/Ci) (Mol),                    (2) 
where Cm is the concentration of the target ion in the membrane and Ci is the 
concentration of the target ion in the analyte solution. When plotting the potential 
difference (ΔE) against the logarithm of the ion concentration (log C), a linear 
section representing ‘the Nernstian behavior’ of the electrodes with the slope of 
59.2/ɀ mV at 25˚ C should represent the ideal value for the electrodes. The shape of 
‘ΔE vs. log C’ plot starts to deviate from a straight line (to more like an ‘S’ shape 
figure) at both ends of the curve. In order to accurately detect both the upper and the 
lower detection limits of the electrodes as recommended by International Union of 
Pure and Applied Chemistry (IUPAC) (Buck and Lindner, 1994), a tangent line 
from each deviated end is intersected with the linear section. The concentration 
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values at the points of intersect are considered as upper and lower detection limit for 
the electrodes. 
Apart from numerous applications of ISEs in various fields of science, they have 
been used broadly in the pharmaceutical field for quantitative analysis of many APIs 
in formulations in the past couple of decades (Aboul-Enein and Sun, 2000; Giahi et 
al., 2010; Khalil and Borham, 1999; Salem et al., 2003; Shamsipur et al., 2002). The 
conventional ISEs that are designed with an internal filling solution containing the 
ion of interest that is connected to the selective membrane, impose problems 
regarding their working conditions, maintenance and lifetime. In the past few 
decades, several breakthroughs have made a massive impact on revitalization of the 
ISE applications. Introduction of all solid-contact ion-selective electrodes (SC-ISEs), 
the progress in deeper understanding of the ion flux through the membrane and the 
influence of interfering ions and most importantly the major improvements in the 
lower detection limits have made great advancements in this field (Sundfors, 2010). 
Today, the SC-ISEs offer numerous advantages such as simple, portable and low-cost 
design, easy maintenance, long durability, appropriately low detection limit, fast 
response time, strong selectivity for a wide range of APIs in solutions or various 
charged electrolytes in the blood and other body fluids, high tolerance in a wide pH 
range, insensitivity towards many common excipients and the possibility to function 
in colored and cloudy solutions. 
Construction of SC-ISEs involves casting of the ion-selective membrane directly on 
the surface of a solid electric conductor which eliminates the internal liquid filling and 
provides simpler design, easier maintenance and more mechanical flexibility and 
robustness. The membrane is the heart of the ISE which is usually made of a highly 
viscous and lipophilic polymeric solution preferably with low water uptake and 
practically fixed composition of carefully selected constituents. The polymeric 
membrane is typically consisting of 66w% plasticizer, 33w% high-molecular weight 
PVC and 1w% of ionophore (Bakker et al., 1997). The mix of the components is usually 
dissolved in an organic solvent with a low boiling point such as tetrahydrofuran to 
achieve a membrane cocktail for casting. The key constituent for the selectivity of the 
membrane is the ionophore substance that enables reversible binding to the target ion 
as the driving force behind the functionality of the electrodes. Bühlmann et al. (1998) 
published a comprehensive review on all classes of readily available ionophores that 
had been used for many target ions. It must be noted that in many cases the ionophore 
substance can be entirely replaced or used together with a lipophilic complexing agent 
(salt) that provides the ion-exchange properties to the membrane as the prerequisite 
for the Nernstian behavior of the electrodes (Mattinen et al., 2009; Sundfors, 2010). 
The two most common lipophilic salts that are used in the membrane are potassium 
tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (KTFPB) and potassium tetrakis(4-
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chlorophenyl) borate (KTpClPB) which are for anion-selective membranes and 
cation-selective membranes, respectively.  
Apart from the constituent of the membrane, the ion-to-electron transducer 
within the SC-ISEs structure is also important in the overall performance of the 
electrodes. In the past, conducting polymers have been widely used as ion-to-
electron transducers (Bobacka, 1999; Bobacka et al., 2008). However, more recently, 
new classes of materials such as microporous carbon (Lai et al., 2007), carbon 
nanotubes (Rius-Ruiz et al., 2011) and most importantly carbon cloth have been 
implemented for such purpose. Mattinen et al. (2011) performed a comparative 
study on ion-to-electron transduction process and concluded that carbon cloth 
offers more qualities than conductive polymers or bare glassy carbon while 
providing even more mechanical flexibility and robustness to the manufactured 
electrodes. The good qualities of the carbon cloth were attributed to its inherently 
high specific surface area, large double-layer capacitance and low impedance at the 
membrane interface followed by a good potential stability.  
2.4.1.1 The working principle of the ISEs 
In the membrane, the lipophilic salt dissociates into two ions, usually a lipophilic ion 
and a smaller hydrophilic ion. The hydrophilic ions (e.g. K+, Ca2+, etc.) must have the 
same charge as the target ions which are actually the ionized API molecules. The 
lipophilic ions in the membrane which are stationed in the membrane with the 
opposite charge as the target ions are called ionic sites. These ionic sites are the 
destination for the flux of target ions to the membrane. The more lipophilic target 
ions have a tendency to substitute the small hydrophilic ions at the ionic sites. The 
electrodes must be conditioned in a solution containing the target ion for several 
days prior to measurements, so that the activity of the migrated target ion in the 
membrane reaches equilibrium. This provides the necessary factor for the electrodes 
to be able to detect any changes in ionic concentration when introduced to solutions 
of unknown concentrations (Bakker et al., 1997). When electrodes are submerged 
into the analyte solution with a different ion concentration as the conditioning 
solution/electrode membrane, a charge separation occurs at the interface of the 
membrane and the bulk of the analyte solution. This charge separation causes a 
phase-boundary potential which is ultimately measured. The degree of lipophilicity 
of the target ions governs the interference of the counterions and dictates the 
lifetime of the electrodes. The inevitable leaching of the complexing agent/ionophore 
into the surrounding aqueous solutions results in depletion of the membrane from 
its active component(s) which subsequently exhibits an undesirable potential drift 
away from the Nernstian behavior (Bakker et al., 1997). 
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2.4.2 Colorimetry 
Color is the primary parameter that highly influences the consumer’s final opinion 
and overall acceptance of any edible products. Analytical techniques that use 
colorimetric measurements in the visible part of the electromagnetic spectrum have 
been explored extensively in the past for quality control of the food products 
(Ansorena et al., 1997; Calvo et al., 2001; Kays, 1999; Meléndez-Martínez et al., 
2003). Since color is not an intrinsic property of an object, the changes in 
illumination conditions (e.g. light intensity) together with the angles of illumination 
and viewing affect the color evaluation (Meléndez-Martínez et al., 2005). Even 
though human vision is highly robust regarding true perception of color, the visual 
color examination is inherently subjected to variation from observer to observer and 
clearly is not practical for large-scale color measurements (Zhou et al., 2011). 
Therefore, in order to conduct an objective analysis, proper color measuring 
instruments have been introduced along with defined color spaces in which each 
color corresponds to certain color components or tristimulus values (Trussell et al., 
2005). Di Wu and Sun (2013) described the color space as ‘mathematical 
representation for associating tristimulus values with each color.’ Three different 
color spaces, namely RGB (red, green, and black), CMYK (cyan, magneta, yellow, 
and key) and CIELAB have been defined to describe color as a number in 3D space. 
CIELAB color space was established in 1976 by Commission International 
d’Eclairage (CIE) and has been adopted as an international standard for color 
measurements by many instruments ever since. CIELAB is a perceptually uniform 
color space which means that ‘the Euclidean distance between two different colors 
corresponds approximately to the color difference perceived by the human eye’. 
Therefore, it estimates/mimics the human color perception and sensitivity with high 
accuracy (Zhou et al., 2011). When using a spectral sensitive tristimulus colorimeter 
in CIELAB color space, the colors are described by three numerical values (vectors) 
of L*, a* and b* in different recommended illuminant/observer settings (Korifi et al., 
2013). L* is the intensity component of the color ranging from the darkest black to 
brightest white (0−100) and parameters a* and b* are the other two chromatic 
components that represent the shift from green to red and from blue to yellow in a 
range of -100 to +100, respectively. Finally, the color difference parameter (ΔE*ab) is 
expressed in Cartesian coordinates according to: 
∆E∗ୟୠ ൌ ඥሺL∗ଵ െ L∗଴ሻଶ ൅ ሺa∗ଵ െ a∗଴ሻଶ ൅ ሺb∗ଵ െ b∗଴ሻଶ,                  (3) 
where (L*1; a*1; b*1) are the measure coordinates and (L*0; a*0; b*0) are the reference 
coordinates.  
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In this manner, using the reflective light mode from the surface of the samples in 
the entire visible spectrum, a complex color as a quality factor can be expressed in 
numerical values for objective quantitative analysis. 
The application of colorimetric techniques in quality control of the pharmaceutical 
products has been limited, even though low-cost and easy to use colorimetric 
instrumentations have been readily available (Zhou et al., 2011). Hetrick et al. (2013) 
used a colorimetric technique to assess the physical appearance and the color coating 
stability of the pharmaceutical dosage forms in accelerated conditions to replace the 
current subjective man-based visual tests for such purposes. Wickstrom et al. (2017) 
further demonstrated the applicability of the same colorimetric device in this thesis for 
estimation of vitamin B1, B2, B3, and B6 amounts in orodispersible formulations. They 
reported that after a certain number of printed layers, the color saturation set the 
upper detection limit for the device. Also, Al Hagbani et al. (2017) used a colorimetry 
in CIELAB color space to identify the imitator products including many forms of 
sildenafil tablets from the innovator Viagra® tablets. The application of such technique 
can avoid major public health concerns in developing countries with poor regulatory 
practice and dominant counterfeiting issues. 
Since most APIs are colorless, both in powder form and in various aqueous or 
organic solutions, an assumption was made for addition of a coloring agent to the 
ink formulation so that the color difference measurement could be feasible. The goal 
was to investigate if a meaningful correlation between the colorimetric coefficients 
and the escalating number of printed layers could be achieved. In this manner, the 
drug content could be indirectly estimated by the applied colorimetric technique 
since the number of printed layers has been consistently proved to be linearly 
proportional to the drug amount in each formulation.  
2.4.3 Vibrational Spectroscopy 
The electromagnetic spectrum is divided into various sections extending from one 
side to the far most regions of ultraviolet and from the other side to the far most 
regions of infrared (Figure 2). 
 
Figure 2. The electromagnetic spectrum in logarithmic scale.  
Matter can absorb, reflect, transmit or scatter light when exposed to the 
electromagnetic radiation. The underlying physical concept of spectroscopy is the 
measurement of the interactions of the inherent electromagnetic field of the sample 
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with the electromagnetic radiation that is subjected to the sample. In classical 
physics, this interaction occurs only if the frequency of the electromagnetic radiation 
matches the frequency of various vibrational modes in atomic bonds within the 
molecules under study (Raghavachari, 2001). Vibrational spectroscopy is the study 
of specific frequencies of light that generate vibrational movements in form of 
symmetric or asymmetric periodic motions such as stretching and bending in 
chemical bonds which alter the energy levels of a substance for a short time.  
Highly versatile vibrational spectroscopic techniques including mid-infrared 
(mid-IR), near-infrared (NIR) spectroscopy and imaging together with Raman 
spectroscopy and imaging provide fast and nondestructive physicochemical analysis 
of pharmaceutical products with little to no sample pretreatment requirements. Each 
spectroscopic technique functions in a specific frequency range of the 
electromagnetic spectrum which dictates the energy level that is radiated to and 
collected from the samples. Lights of specific wavelengths are absorbed or scattered 
in different regions of electromagnetic spectrum according to molecular bonds 
within the sample. The spectroscopic measurement can be used to both identify the 
chemical structure and to quantify the composition of various raw and in 
formulation substances. 
2.4.3.1. NIR spectroscopy 
According to The American Society of Testing and Materials (ASTM), the NIR 
region of the electromagnetic spectrum includes wavelength range of 780–2526 nm 
which is corresponding to the wave number range of 12820–3959 cm-1. The mid-IR 
region extends beyond the NIR region from 4000–400 cm-1 (2.5–25 μm). The most 
prominent absorption bands (peaks) in the NIR region are related to overtones and 
combination of fundamental vibrations of hydrogen bonds such as C–H, N–H, O–
H, etc. These absorption bands which are derived from fundamentals in the mid-IR 
region are normally broad and overlapping where the stronger bands may obscure 
neighboring weaker bands. For this reason, the NIR variables (wavelengths) are 
often partially or completely collinear and the meaningful information is hidden in 
their correlation pattern rather than in individual and selective absorption band 
signals in mid-IR region (Eriksson et al., 2013). Therefore, due to the multivariate 
nature of the data, it is highly unlikely to correctly associate the peaks in the spectra 
to known physical or chemical properties of the samples (Stenlund et al., 2009). 
However, the very existence of peaks in the spectra indicates the relevant chemical 
information and their absence are considered as irrelevant information or noise. 
NIR spectroscopy has been used extensively in the pharmaceutical field as a PAT 
tool for identification and quantification of raw, intermediate and finished 
pharmaceuticals as well as for monitoring of such manufacturing processes. In 
particular, NIR spectroscopy has been employed to study the API content (Järvinen 
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et al., 2013; Martínez et al., 2013), moisture content (Chablani et al., 2011; Mainali et 
al., 2014), quantification of excipients (Karande et al., 2010), the quality of film 
coating (Gendre et al., 2011; Korasa et al., 2016), monitoring various steps of 
production process (Blanco et al., 2010) and other applications.  
The advancements in the field of fiber optics in NIR devices, the computing 
powers of modern instruments and the enhanced chemometric software with user 
friendly interface and useful graphical tools have been the core to higher acceptance 
of NIR spectroscopy in raw material testing, process monitoring and quality control 
in industrial scales (Reich, 2005). However, restrictive specifications and 
requirements of the pharmaceutical regulatory agencies regarding the quality control 
methods and the overall safety of the medicinal products have been the reasons 
behind the slow adoption of NIR spectroscopic techniques in the pharmaceutical 
industry. Such strict regulations are mainly due to the need for additional 
mathematical data analysis for examination and interpretation of the NIR spectra. 
Considering the instrumentation, generally the premiere source of radiation for 
NIR spectrometers is tungsten halogen lamps which are small, inexpensive, stable, 
sturdy and readily available. Detector types include silicon, lead sulfide (PbS) and 
indium gallium arsenide (InGaAs). The silicon detectors are fast, small, inexpensive, 
and highly sensitive mostly in higher overtone regions (750-1100 nm). PbS detectors 
are also sensitive with good signal-to-noise ratio in a wider NIR region (1100-2500 
nm), but they function relatively slower with more difficulty in production and 
operation. InGaAs detectors have been implemented more recently in larger fields of 
applications with combined positive properties of silicon and PbS detectors; 
however, they are much more expensive in comparison (Raghavachari, 2001).  
The NIR spectra are usually collected from the surface of the solid dosage forms. 
This can be problematic for the analysis of the tablets as any given cross section of a 
tablet cannot possibly represent the true amount of API/excipient blend ratio in the 
entire dosage form. Moreover, it is evident that the assay of coated tablets is 
challenging since the spectral information arising from the coating polymers 
strongly affect the data (Reich, 2005). In this regard, the thin and planar surface of 
an orodispersible film offers a great advantage for NIR spectroscopy and imaging 
techniques for analysis of such dosage form in its entirety. 
2.4.3.2. Hyperspectral NIR imaging technique 
The application of hyperspectral NIR imaging in pharmaceutical research and 
development has emerged very recently as a complimentary method to NIR 
spectroscopy. This technique offers the possibility to create concentration 
distribution maps of the constituents at the pixel level so that the overall uniformity 
of the API and the excipients in the final product can also be assessed (Amigo and 
Ravn, 2009). The idea of complete inspection of the microstructure of the 
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formulations in a non-invasive fashion opens up a new quality control platform 
which allows compositional analysis to be integrated in form of convenient and easy 
to interpret color coded computer generated images with little to no sample 
preparation. Once again the enormous amount of hyperspectral data that are 
collected within a short time frame calls for multivariate methods to decode pixel-to-
pixel qualitative, quantitative and spatial information.  
Alexandrino and Poppi (2013) claimed to have used NIR chemical imaging and 
relevant chemometrics for the first time to create quantitative compositional 
distribution maps for both the drug and the excipients in thin film formulations. 
Zidan et al. (2010) used NIR spectroscopy and imaging techniques to evaluate the 
contents of a model protein in nanoparticles and to distinguish between 12 different 
formulations. Pavurala et al. (2017) used NIR hyperspectral imaging to model and 
predict the dry coat thickness uniformity of transdermal patches and to detect and 
identify thickness variations and practical defects related to non-uniform regions 
such as the presence of air bubbles. Franca et al. (2016) was able to monitor the 
degradation pattern of captopril into captopril disulfide in different layers of the 
tablets along with the detection of anomalies consistent with the manufacturing in 
addition to being able to reversely predict the manufacture date of the tablets within 
120 days. Ely and Carvajal (2011) used NIR hyperspectral imaging to quantify the 
scale of segregation, as a quality factor to compare agglomeration of mixtures, in 
compact powder blends of low dose tolmetin (0-10% w/w) and lactose anhydrous as 
the diluent. They reported that a mixture containing 5% (w/w) tolmetin showed the 
best results before the spectral signals from higher percentage of the drug dominated 
the images. In a comprehensive and important review by Amigo (2010) a detailed 
description of advantages as well as practical issues regarding the application of 
hyperspectral imaging and data analysis approaches was published. Amigo (2010) 
stated that the pixel size should be selected according to the particle size of the API 
in the formulation, especially in lower doses so that the API signal remains 
significant. In addition, parameters such as the spatial resolution of the device, 
irregularities in the surface of the samples and the homogeneity of the drug on the 
surface which might not properly represent the entire formulation should be 
considered.   
2.4.3.2.1. NIR hyperspectral imaging configurations 
There are two main methodologies to conduct hyperspectral imaging in order to 
obtain a three-dimensional (X × Y × λ) ‘hyperspectral data cube’; push-broom 
imaging and tunable spectral filter methods (Figure 3). In push-broom imaging, the 
entire range of the NIR wavelengths (λ) is collected simultaneously one line at a time 
(in X direction) as the sample moves on a trail underneath the NIR camera (in Y 
direction) so that the final spectral image is built through line by line spectral 
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sweeping of the samples. In tunable spectral filter method, the entire sample area (X 
× Y) is illuminated throughout the measurement so that the spectral signal for each 
individual wavelength is collected from the entire pixels in view to build the final 
spectral image.  
  
 
Figure 3. The main hyperspectral imaging methods. (a) Push-broom and (b) tunable 
spectral filter. 
In short, in push-broom imaging spatial lines are scanned over time while in 
tunable spectral filter the wavelength is scanned over time. Push-broom imaging has 
more advantages due to simpler illumination standards, higher imaging speed and 
mainly because of the significant reduction in the heat load exerted to the sample as 
a result of line illumination of a moving sample that allows less damaging exposure 
time to the NIR light. More importantly, the push-broom method is designed for 
online process monitoring of products where samples are usually in a continuous 
movement along the production line. 
2.4.4 Chemometric analysis 
2.4.4.1 Data pretreatments 
Data pretreatment is usually performed prior to multivariate modeling to reshape 
the data with least possible signal distortion, remove the irrelevant variations and 
artifacts such as background effect e.g. from substrate, eliminate nonlinearities and 
skewed distribution of single variables and finally to remove the baseline shift and 
slope for proper data analysis. However, using such mathematical modifications 
always leaves the risk of unintentional removal of some spectral features that may 
contain useful information. Therefore, it is important to select appropriate treatment 
methods according to the type and nature of the data in hand. One must consider 
that preprocessing cannot compensate for poor data quality, but often can make a 
good model better. Pretreatment techniques are mainly either scatter correction 
methods such as multiplicative scatter correction (MSC) and standard normal 
variate (SNV) or derivation methods such as Savitzky-Golay (SG) or Norris-
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Williams. Such techniques and various similar methods have been discussed 
extensively in the literature (Barnes et al., 1989; Rinnan et al., 2009; Savitzky and 
Golay, 1964). In this thesis, the focus was on SNV scatter correction and Savitzky-
Golay smoothing and derivation techniques.  
2.4.4.1.1. Standard normal variate and Savitzky-Golay techniques 
SNV is the second most used scatter correction technique after MSC. It works by 
subtracting the mean spectrum from the original spectrum and dividing it by 
standard deviation as the scaling factor for removing the artifacts or the scatter effect 
in the data. The signal-correction principle for SNV is the same as MSC, but the 
signal correction is not reference based. Thus, each spectrum is processed alone with 
no regard to the remaining of the data set. The minor differences between the two 
methods are related to a simple rotation and offset correction (Rinnan et al., 2009). 
SG smoothing technique scans through the spectra in a polynomial form and 
approximates the smoothing and derivation for each variable separately in a single 
step (Vivó-Truyols and Schoenmakers, 2006). There are three parameters that 
should be decided before SG smoothing. The number of smoothing points which is a 
window of odd number of adjacent variables, so the point to be smoothed always 
situated in the center, the polynomial order of the best fit smoothing function and 
the degree of derivation. Normally a first derivative with 5-9 points or a second 
derivative with 7-11 points are used together with a 2nd or 3rd degree polynomial 
order as the common practice in NIR community. As the degree of derivation 
increases, the signal-to-noise ratio decreases. Thus, if a 3rd degree derivative 
approach is selected, it is only logical to select a wider window of smoothing points 
(e.g. 15 points) and the lowest polynomial order. This can increase the signal-to-
noise ratio and the resolution of the overlapping bands as well as in between the 
spectra in the search to find the optimal smoothness (Reich, 2005). 
2.4.4.2 NIR data analysis 
After a successful smoothing and scatter correction, there is a need for reduction of 
variables so that the data variability could be explained by a few uncorrelated vectors 
for easier understanding of the trends in the dataset and subsequently building 
stronger predictive models. Therefore, chemometric analysis usually in the classic 
form of principal component analysis (PCA) and the partial least squares (PLS) 
regression is essential to process the multivariate NIR data.  
PCA remains the primary statistical procedure to reduce the complexity and to 
redefine the multidimensional data by using a set of orthogonal vectors called 
principal components (PCs). The data points are then projected onto a new 
coordinate system with PCs axes in order to explain the largest possible variance 
within the data and to classify the observations (Jolliffe and Cadima, 2016). The first 
principal component (PC1) is a vector that passes through the long axis of the data 
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cloud corresponding to the maximum variance within the data in its direction. The 
second principal component (PC2) is then created perpendicular to the first one in 
the direction of the next highest variance with intersection at the centroid of the 
mean-centered data. Each successive PC explains the remaining portion of the 
variability in their respective orthogonal direction to the other PCs. 
In pharmaceutical applications, usually a high portion of the variations in the 
NIR spectra can be expressed using only a few PCs. PCA models with higher number 
of PCs are considered as overfit models which may not necessarily equate to higher 
predicting qualities. Such complex calibration/training models usually fail when they 
are validated using independent datasets, even though they may have high regression 
coefficient (R2) and a small root mean square error of cross–validation (RMSEcv) 
(Reich, 2005). 
2.4.4.2.1. PLS and OPLS regression methods 
PLS regression is a well-known, well-described and widely used multivariate data 
analysis method that accounts for multicollinearity (highly correlated variables) and 
missing values in the variable/predictor matrix X for making reliable regression 
coefficients (Homayoun et al., 2011). PLS as a mathematical model starts with the 
assumption that there is a meaningful interrelationship between the two matrices of 
X and Y and then tries to find the best possible tactic to link the two matrices so it 
can finally be able to predict the outcome Y from X (Erikson et al., 2013). As 
opposed to PCA which only explains the variations within the X matrix, PLS 
explains the systematic variations in the X matrix that are related to the variations in 
the Y matrix (Sadeghi-Bazargani et al., 2011).  
Trygg and Wold (2002) introduced orthogonal projections to latent structures 
(OPLS) as a modification to PLS. The OPLS method can further maximize the 
explained covariance between X and Y matrices by excluding the orthogonal or 
systematic variations in X that was not linearly correlated to Y and explaining such 
variations separately. The portion of the variables in the X matrix that contribute 
directly towards predicting the Y is modeled independently and a new vector ‘R2x 
(predictive)’ is introduced instead of the PC1 in the PLS method. Thus, OPLS offers 
an advantage over the more traditional PLS method by reducing the model 
complexity, excluding non-correlated variation in the X matrix and more 
importantly improving the interpretation of the data. OPLS also adjusts the 
projection of the observations in the score plot of the PLS with enhanced separation 
between different classes so that partitioning of the observations would be more 
consistent with the chemical assumption behind the experimental design of 
experiments (DOE). In NIR spectroscopic analysis using a single column Y matrix, 
the OPLS method ‘rotates’ all the relevant predictive information into only the first 
axis (R2x (predictive)) on the score plot so that the systemic separation between the 
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observations would align properly with the linear increase of the API dose in one 
direction. 
However, in the single Y scenario, which is usually the case for spectroscopic 
data, both PLS and OPLS are absolutely identical and there is no distinction between 
the predictive abilities of such techniques.  
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3. Aims of the study 
This thesis was focused on two main topics. The first objective was to study the 
manufacturing of uniform and accurately tailored doses of oral dosage forms using 
inkjet printing technologies for precision medicine. The second and main objective 
was the investigation of various analytical techniques in quality control of the 
printed formulations.  
In addition, the molecular-level interactions between the drug and the excipients, 
the solid-state properties of the drugs in the formulations and the degradation 
tendency of the drugs under different storing conditions were studied.  
Complementary techniques were also applied to various extents for each project to 
further study the effect of printing on the substrates and the mechanical and 
disintegration properties of the produced orodispersible formulations. 
The specific objectives in more detail were to: 
 Gain a deeper and more insightful understanding of the physicochemical 
properties and interactions of different drug substances in the various ink 
solutions when printed on different carrier substrates. 
 Develop and study the quality of ion-selective electrodes (ISEs) using the 
potentiometric analysis for the study of drug release from different polymeric 
films and cellulose-based porous substrates. 
 Study the integrated use of inkjet and flexographic printing technologies to 
produce accurately dosed medicine with control over the drug release profiles 
by polymeric coating of already inkjet printed formulations. 
 Investigate the feasibility of hyperspectral NIR imaging together with 
chemometrics to build quantitative predictive models as well as qualitative 
concentration maps to allow digital and visual assessment of both the API 
amount and the uniformity of its distribution on inkjet printed systems. 
 Study the use of a handheld colorimetric device for indirect measurement of 
the API dose in printed orodispersible delivery systems for pediatrics. 
 Investigate the application of a compact handheld NIR probe for prediction 
of the drug dose on different edible substrates with the potential to be 
installed in-line in a continuous manufacturing scenario. 
Materials and methods 
 28
4. Materials and methods 
4.1. Materials 
4.1.1. Active pharmaceutical ingredients 
Propranolol hydrochloride (Sigma, St. Louis, MO, USA and Fagron, Copenhagen, 
Denmark) (I, II, IV), lidocaine hydrochloride monohydrate (Sigma, St. Louis, MO, 
USA) (I), riboflavin sodium phosphate (RSP, riboflavin 5´-monophosphate sodium 
salt, Ph. Eur., Fluka Analytical, Sigma–Aldrich, France) (II),  anhydrous theophylline 
200 M (Orion Pharma, Espoo, Finland) (III), levothyroxine sodium salt 
pentahydrate (≥98%, Sigma–Aldrich Co., Italy) (V) and prednisolone (≥99%, 
Sigma–Aldrich Co., China) (V) were all used as the model APIs (Figure 4). 
 
Figure 4. Chemical structures of the APIs. 
4.1.2. Excipients 
Ethylcellulose (EC, Sigma, St. Louis, MO, USA; ethoxy content, 48–49.5%; viscosity, 
45 cP) (I-II) A), hydroxypropyl cellulose (HPC, Shin-Etsu, Japan (I, V) and Klucel® 
EXF, Ashland, Wilmington, DE, USA (IV)), hydroxypropyl methylcellulose (HPMC, 
Pharmacoat® 606, Shin–Etsu, Wiesbaden, Germany) (V), propylene glycol (PG, 
≥99.5%, Sigma–Aldrich, Germany) (II, V), glycerol (≥99.5%, J.T. Baker, Deventer, 
Holland) (II, IV, V), saccharin sodium salt hydrate (≥98%, Sigma–Aldrich Inc., 
USA) (IV) and edible ink (V) which was consisted of water, glycerol (E422), brilliant 
black (E151), sunset yellow (E110), tartrazine (E102), ponceau 4R (E124), azorubine 
(E122), brilliant blue FCF (E133), propylene glycol (E1520) and citric acid (E330) 
(Deco Enterprises Ltd, London, UK) were used as model excipients. Potassium 
dihydrogen phosphate and hydrochloric acid (≥37%, Sigma–Aldrich Inc. (St. Louis, 
MO, USA) (I, IV) were used for the preparation of assay and dissolution 
media.  Ethanol (≥96.1%, Etax A, Altia OYj, Finland) and double-distilled water 
(Milli-Q) (I-IV) were used as solvents throughout this entire study. 
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4.1.3. Commercially available substrates 
Uncoated filter paper (138 g/m2, Whatman International Ltd, Maidstone, England) 
(I), alkyl ketene dimer-sized uncoated woodfree paper (A), triple-coated inkjet paper 
(B) and double-coated sheet fed offset paper (C) (Sappi Fine Paper Europe, Brussels, 
Belgium) (II), uncoated copying paper (Optitext, 80 g/m2, Stora Enso Oyj Fine 
Paper, Oulu, Finland) (III), edible icing sheet (EIS, Sutton Valence, Kent, UK (IV) 
and Culpitt Ltd, Ashington, UK (V)) and edible rice paper (ERP, N.J. Products Ltd, 
Birstall, UK) (IV) were used as commercially available porous carrier substrates. 
4.1.4. Electrodes membrane 
Polyvinyl chloride (PVC), 2-nitrophenyl octyl ether (NPOE), potassium tetrakis(4-
chlorophenyl) borate (KTpClPB) and tetrahydrofuran (THF) were all Selectophore 
reagents from (Fluka, Hauppauge, NY, USA) (I) which were used for preparation of 
ISE membrane cocktail along with carbon cloth (Kynol® activated carbon fabric 
ACC-5092-20, Kynol Europa GmbH, Hamburg, Germany) (I). 
4.2. Methods 
4.2.1. Preparation of polymeric substrates by solvent casting 
In addition to the commercially available substrates, 2 types of blank polymer 
substrates were prepared manually by solvent casting using a film applicator 
multicator 411 with 220 mm gap width and wet coating thickness of 500 μm 
(Erichsen, Hemer, Germany). In paper (IV), a film containing HPC:ethanol (15:85 
w/w%) was applied on top of the edible rice paper (ERP) to create a modified carrier 
substrate and in paper (V), a polymer film containing HPC:HPMC:glycerol:ethanol 
(7.5:7.5:5:80 w/w%) was prepared on top of an impermeable transparency film 
(Dataline™, Transparency film, code 57170, EU) which only served as liner and later 
was detached from the polymer film during analysis (V). The created substrates were 
dried in ambient conditions (20 ± 5% relative humidity (RH) and 24 ± 1 °C) for 24–
48 h before printing. 
4.2.2. Preparation of formulations (I–V) 
4.2.2.1. Drug-polymer solvent casting (I) 
Nine drug-polymer solutions with different compositions containing 2 APIs and 2 
polymers of various weight ratios were prepared. All the solutions were subsequently 
drop-casted by a pipette into a Teflon mold (Ø 20 mm) to create 9 different thin-film 
formulations and three of these solutions were drop-casted by the pipette onto the 
surface of the uncoated porous cellulose-based substrates (Ø 28 mm) to create 3 
additional formulations for paper (I) (n = 3) (Figure 5). In order to accomplish this, 
the mixed powder of the drug and polymers were first dissolved in ethanol with the 
ratio of 1 g in 5ml of the solvent at 60 °C in an ultrasound bath for 15 min. 1 ml of 
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each drug-polymer solution was then used for the making of each film on the Teflon 
mold and 0.5 ml of this solution was deposited on the porous cellulose substrates. 
The created formulations were left to dry in a desiccator containing silica gel at room 
temperature for 24 h before starting the dissolution measurement. 
 
Figure 5. Different manually designed formulations for paper (I). 
4.2.2.2. Dimatix and flexographic inkjet printing (II) 
A Dimatix DMP-2800 inkjet printer (Fujifilm Dimatix Inc., Santa Clara, California) 
with a MEMS-based cartridge-styled printhead which had 16 nozzles linearly spaced 
at 254 μm to produce a typical drop size of 10 pl was used to inkjet print 
formulations containing propranolol hydrochloride and riboflavin sodium 
phosphate for paper (II). The ink solutions were 50 mg/ml propranolol powder in 
PG:water mixture (30:70, vol%) and 31.5 mg/ml of riboflavin powder in 
glycerol:ethanol:water (10:10:80, vol%). The ink solutions were filtered into each ink 
cartridge with a volume of 1.5 ml at 30 ˚C using 0.45 μm and 0.2 μm polypropylene 
membrane filters (Whatman™, GE Healthcare, Piscataway, NJ, USA). Printing was 
performed on squared areas of 1 cm2 (n = 10-20) on the substrates using a single 
nozzle (Ø 20 μm) with drop spacing of 10 μm and firing voltages of 30 V and 35 V 
for propranolol and riboflavin, respectively. According to the Dimatix software the 
total number of 1,002,001 drops with a drop volume of 10 pl were deposited onto a 1 
cm2 area of each substrate which was theoretically corresponding to approximately 
10.02 μl/cm2. The theoretical printed drug amount was calculated to be 0.501 mg for 
propranolol and 0.316 mg for riboflavin formulations. 
A laboratory scale printability tester (IGT Global Standard Tester 2, IGT Testing 
system, The Netherlands) was used for contact flexographic printing of a polymer 
coating ink consisting of EC:ethanol (5:95 w%) on top of the already Dimatix 
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printed formulations for paper (II) (Figure 6). The coating polymer was applied 
locally to a small area of the anilox roll with a cell angle of 45˚, a cell volume of 20 
ml/m2 and a line count of 40 l/cm. The rotating anilox roll was in contact (P = 100 
N) with the plate roll with a selected relief pattern on its surface as the printing 
template. The plate roll was also in contact (P = 50 N) with the impression roll with 
the earlier Dimatix printed substrates attached to its surface. During printing the 
anilox roll rotated at the printing speed of 0.5 m/s in order to distribute the ink 
evenly on its surface while the excess coating ink was removed by the doctor blade. 
Through one spin of the rotating system, the polymer ink was transferred from the 
anilox roll onto the relief pattern of the printing plate and subsequently was coated 
as one layer on the substrate. The formulations were coated on both sides with 5 and 
30 layers of EC solution to study the effect of the polymer coating on the drug 
release. All the printings procedures were carried out in ambient conditions (45 ± 
5% relative humidity (RH) and 21 ± 2 ˚C).  
 
Figure 6. The flexographic printing unit. 
4.2.2.3. Thermal and piezoelectric inkjet printing (III–V) 
Concentrated API containing ink solutions were used to fill empty black cartridges 
of commercially available desktop thermal inkjet printers and the refillable container 
of the piezoelectric inkjet printer. A solution of 20 mg/ml of anhydrous theophylline 
in glycerol:water:ethanol (10:45:45 vol%) was replaced in the cartridge of a Pixma 
MP495 (Canon Inc., Japan) (III). A solution of 50 mg/ml propranolol hydrochloride 
ink solution in a mixture of water:glycerol (90:10 vol%) was transferred in the 
cartridge of a Pixma iP7250 (Canon Inc., Japan) (IV). Solutions of 40 mg/ml 
prednisolone and 20 mg/ml levothyroxine sodium in DMSO:ethanol:PG (45:45:10 
vol %) were used as separate inks on a PixDro LP 50 piezoelectric inkjet printer 
(Roth & Rau, Eindhoven, Netherlands) (V). Glycerol and PG were added to the ink 
solutions as moisturizing agents, viscosity modifiers and to prevent the nozzles from 
blocking. All the ink solutions were filtered with 0.2 mm polypropylene membrane 
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filters (What-manTM, GE Healthcare, Piscataway, NJ, USA) before printing. In 
order to achieve escalating dose systems, multiple superimposed layers (1-32) were 
printed with thermal inkjet printers (III-IV) while different print resolutions (from 
500 × 500 dpi to 1000 × 1000 dpi) were used to obtain the escalating drug doses 
when using the piezoelectric inkjet printer (V). 
The printing parameters on thermal inkjet printers were set to normal print 
quality and resolution. The printing parameters for the piezoelectric inkjet printer 
were set as follows: a Spectra® SL–128 AA printhead with 128 nozzles (Ø 50 μm) and 
spacing of 508 μm; the ink pressure and the jetting voltage were set at −18.30 mbar 
and 85 V, respectively; the time to reach the fixed voltage was set at 3 μs, the time 
period of applied voltage on the piezoelectric element was between 17−18 μs and the 
time for the voltage drop was set between 3−4 μs. 
The drug delivery systems were printed on squared areas of 1 cm2, 2 cm2 and 4 
cm2 on different substrates according to the templates that were digitally designed in 
Microsoft Power Point 2010 (Microsoft Inc.). 
4.2.3. Texture analysis and disintegration time of substrates (IV–V) 
Tensile strength (N/mm2), puncture resistance (kPa), distance at burst (mm) and 
elongation percentage of the substrates were measured before and after printing by a 
TA.XT plus texture analyzer (Stable Micro Systems Ltd., Surrey, UK). For tensile 
strength measurement, a self–tightening roller grips probe was attached to both ends 
of the substrates and the maximum force (N) at the point of break was divided by 
the cross–sectional area (mm2) of each substrate to calculate the tensile strength. For 
puncture resistance measurements, a spherical stainless steel probe P/5 (Ø 5 mm) 
was attached to the load cell and was lowered to puncture the substrate that was held 
in place by a set of clamping rings (Ø 1 cm). The resistance (kPa) of the substrates 
against the perpendicular penetration of the probe on the circular area as well as the 
distance of penetration (mm) at which the first fracture (puncture) appeared on the 
surface of the substrates were reported. The speed of the moving tensile and the 
puncture probe were set to 1 mm/sec. (n=10). 
The system for the disintegration test included a sample holder unit clamped on 
the top corner of the substrate with the area size of 2 cm2. Preis et al. (2014) 
suggested that a force of 0.03 N could approximate the minimal force applied by 
human tongue when licking on a probe. Therefore, different weights of 1, 3 and 5 g 
were attached to the bottom corner of the substrate to simulate the exerting force of 
the tongue. The substrate was then gently introduced into a phosphate buffer 
medium (pH 6.0) as the starting point for the disintegration test. The time period for 
the bottom half of the substrates to break apart after entering the buffer medium was 
recorded and reported as the disintegration time (n=10). The temperature of the 
buffer medium was maintained at 37 ± 0.5 °C, while the relative humidity (RH) 
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during the experiments was recorded to be 45 ± 5 % for paper (IV), while these 
conditions were 23 ± 1 °C and below 15 % RH for paper (V). 
4.2.4. UV spectroscopy for content and dissolution analysis (I–V) 
The making of the calibration plots, the drug content measurements and the 
dissolution analyses of the formulation units were performed using four different 
UV-Vis spectroscopic devices throughout this thesis. Each solution was incubated 
for at least 2 h in a buffer solution medium (pH 1.2 and 6; T = 20 ± 5 ˚C for assay 
and 37 ˚C for dissolution). The incubated solutions were filtered with 0.2 μm 
polypropylene membrane filters before the measurements in a transparent cuvette 
with a path length of 1 cm. The maximum absorbance values of each drug were 
recorded at a specific wavelength known as the wavelength of maximum absorbance.  
A PerkinElmer UV-Vis spectrophotometer (Lambda 25, USA) was used for 
measurements of lidocaine hydrochloride (λ = 263 nm), propranolol hydrochloride 
(λ = 289 nm) and riboflavin sodium phosphate (λ = 267 nm) samples (I and II); a 
Cary 50 UV–vis spectrophotometer (Varian Medical Systems, Inc. Palo Alto, 
California, USA) for theophylline anhydrous (λ = 213 nm) (III); a Ultrospec 2100 
pro spectrophotometer (Biochrom Ltd, Cambridge, England) for propranolol 
hydrochloride (λ = 289 nm) (IV) and a NanoDrop 2000c UV−Vis 
Spectrophotometer (Thermo Scientific™, MA, USA) was used for prednisolone (λ = 
248 nm) measurements (V). 
4.2.5. HPLC Content analysis (V)  
The calibration plot and the levothyroxine sodium (λ = 225 nm) content of the 
formulations were measured using a Merck HITACHI LaChrom series HPLC 
(Tokyo, Japan) consisting of a quaternary pump, an automatic injector, a variable 
wavelength detector and a column oven. Data were collected using Merck HITACHI 
D–7000 HPLC system manager and Chromatography Data Station software. The 
separation of the drug-excipient mixture was achieved using a Phenomenex C18 
column (Gemini–NX, 100 x 4.6 mm, 3μm) fitted with a Phenomenex guard column 
(C18 4 X 2.0 mm). The mobile phase was consisting of A: 0.01M Phosphate buffer 
(pH 3.0) and B: Methanol (100%) with a flow rate of 1.0 ml/min. The 
chromatographic gradient was consisting of solvent 45–20% A in the first 7 min, at 
20% A from 7 to 12 min, 20–45% A from 12 to 16 min and at 45% A until 20 min 
(Collier et al., 2010). The column temperature was fixed at 30 °C. The injection 
volume was 50 μl. A solution of water:methanol (95:5 vol%) was used as the assay 
medium. Samples were filtered with 0.2 μm polypropylene membrane filters. 
4.2.6. ISEs and the potentiometric measurements (I) 
For paper (I), the potentiometric measurements were carried out with an EMF 16 
Interface potentiometric device (Lawson labs, Inc., Phoenixville Pike, USA) in a 100 
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ml buffer solution (pH 1.2) as the dissolution medium while stirring at 300 rpm with 
an IKA® RCT hotplate magnetic stirrer (Staufen im Breisgau, Germany) at 37 ˚C.  
The reference electrode was a conventional single junction electrode (Metrohm, 
Switzerland) consisted of an Ag/AgCl wire in an enclosed solution of 3 M KCl. The 
small-scale solid-contact ISEs were manually designed by the author and were used 
as working electrodes. The outer body of the electrodes was made of hollow PVC 
cylinders. Carbon cloth (Kynol® activated carbon fabric ACC-5092-20, Kynol 
Europa GmbH, Hamburg, Germany) was used as the ion-to-electron transducer 
material inside the hollow cavity of the cylindrical electrode bodies (Figure 7). The 
carbon cloth was connected to the potentiometric device at one end and the solid 
electrode membrane at the other end which is usually immersed in the 
conditioning/measuring solutions. The electrode membrane cocktail (450 μl) was 
consisting of PVC:NPOE:KTpClPB (33:66:1 w%) that were dissolved in THF as the 
solvent with the ratio of 1:5 w%. Portions of 100 μl membrane cocktail were drop-
casted directly on one end of the electrodes in time intervals of 30 min for practical 
reasons. The membranes were air dried at room temperature for 2 days. Three 
parallel ISEs were prepared (Figure 8) and each were conditioned for 3 weeks prior 
to measurements in separate diluted HCl solutions (pH 2) containing propranolol 
hydrochloride (0.295 mg/ml) and lidocaine hydrochloride (0.267 mg/ml).  
 
Figure 7. The schematic of the ISEs. Left: hollow PVC cylinder with carbon cloth 
inserted inside; middle: top view with the polished end and right: the membrane 
cocktail deposited onto the polished end and diffusing into the carbon cloth. 
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Figure 8. (a) The manufactured ISEs and (b) the view of the solid-contact membrane 
at the tip of the electrodes. 
4.2.7. Hyperscpectral NIR imaging (III) 
For paper (III), a push-broom SisuCHEMA hyperspectral imaging instrument 
(SPECIM, Spectral Imaging Ltd. Oulu, Finland) equipped with a SPECIM mercury 
cadmium tellurium (MCT) based spectral camera for optimal sensitivity and signal-
to-noise ratio was used to collect the NIR image of the entire escalating system of 
printed theophylline anhydrous formulations (Figure 9). The obtained image quality 
was 256 × 320 pixels with 0.3125 mm spatial resolution per pixel for a sample with 
100 mm width. The spectral range of 942–2542 nm with steps of 6.25 nm including 
256 individual spectral bands was collected for each pixel resulting in 81920 separate 
spectra for the image in less than 7 seconds. 
 
Figure 9. SisuCHEMA hyperspectral imaging device (SPECIM, Oulu, Finland). 
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4.2.7.1. Hyperspectral data cube pre-treatment and PLS regression model 
All the data acquisition, pre-processing and multivariate analysis were performed 
using the Evince Image software (UmBio Umeå, Sweden). The collected spectral 
range was reduced to 1000–2500 nm to mask the anomalies, artifacts and the noise 
that were extremely deviating from the main data cloud on t1/u1 score plot. The 
reflectance hypercube data was mean centered and treated with standard normal 
variate (SNV) scatter correction prior to multivariate analysis. PCA was used to 
classify the collected observations on the pixel level into color coded images in order 
to visualize the interrelationships within the data. A PLS calibration model was then 
created based on 4 of the separate printed unit areas for prediction of the API 
content. Each printed unit on PCA contour 2D plot was then correlated to their 
equivalent API content that was measured earlier by the UV spectroscopic 
technique. The software allows the user to select an area down to pixel levels to 
predict the corresponding drug amount in that specific location. 
4.2.8. Colorimetry measurements (IV) 
For paper (IV), a CLM-194 handheld digital tristimulus colorimeter (EOPTIS, Trento, 
Italy) (Figure 10) was used with an integrated LED illuminator and the measurement 
area of 10 mm in diameter. The CLM-194 Interface software associates each color to a 
single parameter known as ‘color difference (ΔE*ab)’ in the three dimensional 
CIELAB color space. Color difference values are in fact the 3D Euclidean distance 
between the 3 numerical values of L*, a* and b* recorded from each of the printed 
units and the same numerical values measured from a reference color of only one 
printed layer. The circumferential geometry (45˚ C:0˚) was selected according to 
ASTM E 1164 standard to exclude the undesired specular component (gloss). CIE 
standard illuminant D65 and CIE 1931 2˚ standard colorimetric observer were 
selected for illuminant-observer pair selection. The samples were studied on reflective 
mode for all the measurements under the same condition (n = 3). The graphical color 
distribution maps of the printed formulation were presented in CIELAB color space 
for the three different substrates. Moreover, the validation plots of ΔE*ab values vs. 
number of printed layers were reported. 
 
Figure 10. The CLM-194 handheld colorimeter (EOPTIS, Trento, Italy). 
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4.2.9. NIR data collection (V) 
For paper (V), a compact handheld high–performance NIR spectral device N2.0 
(Spectral Engines Oy, Helsinki, Finland) (Figure 11) with single element extended 
indium gallium arsenide (InGaAs) detector was used to collect the NIR absorbance 
spectra in the range of 1550−1950 nm with 5 nm steps. The NIR illumination source 
was made of two tungsten vacuum lamps which were set to 50% of the lamps voltage 
during the measurements. The reflected NIR light was collected through the 
detection aperture (Ø 1 mm) in the center at 2 mm above the surface. One spectrum 
was collected from a random spot on the surface of each parallel printed unit 
containing prednisolone or levothyroxine sodium. 
 
Figure 11. The handheld NIR probe (Spectral Engines Oy, Helsinki, Finland). 
4.2.9.1. NIR data treatment and modeling 
The obtained NIR spectra was imported to SIMCA® 14.1 software (MKS Umetrics, 
Umea, Sweden) for systematic data treatment to standardize the modelling method. 
The spectra were mean centered without scaling and a Savitzky–Golay (SG) 
smoothing technique was applied to the data prior to analysis using a 15-points 
window width and a quadratic polynomial approach. Having considered all the 
combinations of all available scatter correction and derivative techniques in the 
software, a SG approach with the 3rd derivative using 15 points and 2nd order 
polynomial smoothing function was selected for the models. Principal component 
analysis (PCA) and orthogonal projections to latent structures (OPLS) were 
executed on datasets to classify the observations and to build predictive models 
based on the filtered and numerical differentiated data. For authentic validation, 
each dataset was partitioned into a training set and a validation set to evaluate the 
predictive ability of each model. The goodness of prediction (Q2), the goodness of fit 
(R2), the predictive portion of the variables R2X (predictive), the cumulative sum of 
explained variables (R2X (cum)), the number of principal components that best 
described each model as well as RMSEcv values were reported. Subsequently plots of 
raw and differentiated spectra, scatter score plots and plots of observed vs. 
predictions were presented for each model. 
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 4.2.10. SEM and EDX analysis (IV, V) 
A SEM (LEO Gemini 1530, Oberkochen, Germany) equipped with a thermo 
scientific ultra-dry silicon drift detector was used to study the surface morphology of 
the blank and the printed substrate for paper (IV) and paper (V). All samples were 
coated with carbon by using a vacuum evaporator prior to scanning. SEM images 
were obtained at an accelerated voltage of 8 kV with 100× and 2500× magnifications. 
The images were taken using the secondary electron detector while the pressure was 
kept constant at 2 × 10-5 mbar during scanning.  
Energy-dispersive X-ray analysis (EDX) was performed in extension to SEM by 
using an energy-dispersive spectrometer (Thermo Scientific, Madison, Wisconsin, 
USA) in order to identify the elemental composition of various regions on the 
surface of the printed units for paper (V). The EDX analysis was carried out with 
magnifications of 500× and 1000×, image resolution of 1024 × 768 and image pixel 
size of 0.12–0.24 mm at an accelerated voltage of 15 kV. 
4.2.11. Scanning white light interferometry (SWLI) (II, IV) 
A custom-made SWLI instrument with a NIKON reflective microscope frame (6.3× 
magnification) equipped with a 10x MIRAU interferometry objective (NIKON IC 
Epi Plan DI, Japan), a 100 μm piezoelectric z-scanner (Physik Instrumente P-721 
PIFOC®, Karlsruhe, Germany), a high-resolution CCD camera (Hamamatsu Orka 
Flash 2.8 CMOS, Hamamatsu City, Japan), a standard halogen lamp as the white 
light source and two motorized translation stages (STANDA 8MTF-102LS05, 
Vilnius, Lithuania) was used to study the surface topography of the printed 
formulations for paper (II) and (IV). The scanning and the data collection were 
achieved with a C++ based software built in-house. The 3D-image construction and 
the 3D-data analysis were performed using the commercial MountainsMap® 
Imaging Topography 7.2-software (Digital Surf, Avencon, France). The surface 
roughness (Sq) values were calculated according to ISO 25178 standard (n = 3). 
4.2.12. ATR–IR (IV, V)  
An attenuated total reflectance infrared (ATR–IR) Spectrum Two spectroscopic 
instrument (PerkinElmer, UK) with a single reflection artificial diamond ATR 
crystal was used to collect the infrared spectra of the raw substrate, the printed 
formulations and the API containing inks in the region of 450–4000 cm-1 to study 
the solid-state of the drug after printing and the stability of the ink during a 24 h 
period for paper (IV) and (V). A force gauge of 75–80 N was applied to the films 
during the analysis. The baseline was corrected for all the spectra. All the ATR-IR 
spectra were obtained with a 4 cm-1 resolution. 
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4.2.13. DSC measurements (IV, V) 
A differential scanning calorimetric (DSC) instrument (Q2000, TA Instruments Inc., 
USA) was used to study the solid-state properties of the drug and its possible 
recrystallization in the formulations after the storage time. Pure drug powder and 
printed samples of 1.5–6.4 mg were subjected to a heat ramp of 10 ˚C/min from 40 
˚C to 200 ˚C in Tzero aluminum pans and lids with a flow of 50 ml/min nitrogen gas 
in the furnace chamber. 
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5. Results and discussion 
5.1. General remarks 
This research shows the clear advantages of various inkjet printing technologies to 
manufacture precise and uniform doses of drugs on ODFs for precision medicine. 
Additional polymeric coatings were applied to the printed formulations using either 
a coating knife or by flexographic printing to investigate the effect of coating on the 
drug release profiles as well as for higher palatability purposes. Furthermore, surface 
morphology, surface roughness, mechanical properties, disintegration behavior, 
solid-state properties and stability of the printed formulations were examined to 
various extents in each project.  
The present thesis applied the latest analytical advancements in the field to 
investigate the possibilities of their application as fast, low-cost and reliable 
alternatives to the conventional methods of quality control that are currently 
available for the new printed formulations. The robust SC-ISEs were used as an 
inexpensive and powerful alternative to UV spectroscopic methods for drug release 
studies of the solvent-casted formulations. The hyperspectral NIR imaging technique 
provided an easy-to-interpret visual quality control approach to simultaneously 
predict the content and the spatial distribution of the API in the printed 
formulations. A colorimetric instrument was used to estimate the API content of the 
escalating dose systems on different edible substrates that were produced by thermal 
inkjet printing. Finally, a handheld NIR spectrometer was used along with 
multivariate data analysis techniques to predict the amount of two poorly soluble 
APIs on different edible substrates.  
5.2. Visual characterization of the printed dosage forms 
It is highly important for the reader to visualize the shape and the morphology of the 
printed dosage forms for better understanding of the discussions regarding such 
formulations. The formulations were printed on several edible and inedible 
substrates/carriers in the shape of squares of different area sizes (1, 2 or 4 cm2) for 
different projects. The dose tuning was achieved either by printing multiple layers or 
by variation in the print resolution in terms of drops per inches (dpi). Figure 12 
shows an example of a digital camera image of one set of printed formulations that 
was prepared by piezoelectric printing for paper (V) to demonstrate the physical 
appearance of a typical printed system. The red coloring agent was added to the ink 
solely for the visualization purpose. 
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Figure 12. A typical set of printed formulations on edible icing sheet substrate and the 
NIR probe. 
The surface morphology of the blank and printed substrates was visualized on 4 
substrates by scanning electron microscopy (SEM) for paper IV and V (Figure 13).  
 
Figure 13. Scanning electron microscopy images of various printed formulations with 
magnifications of 100× (100 mm scale bar) and 2500× (2 mm scale bar). 
The porous structure and the cavities of variable sizes were detected for the edible 
rice paper (ERP) that contained potato starch and vegetable oil (Figure 13(a) and 
(d)). The structure of this substrate became even more fractured as the number of 
printing layers increased and the ink started to interact with the starch matrix to 
form a coarse surface in case of the highest printed layer (Figure 13(b) and (c)). The 
smooth surface of the coated edible rice substrate (CERP) (Figure 13(g)) was 
transformed to a more uneven surface after 2 layers of printing (Figure 13(h) and 
(k)) and as printing layers increased to 16 layers (Figure 13(i) and (l)) the HPC 
coating layer fragmented and formed irregular aggregates. The glucose particles on 
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the surface of the blank edible icing sheet (EIS) (Figure 13(m) and (p)) were 
observed. The white spots on the glucose particles were of titanium origin which was 
a constituent of this substrate. The particles were covered by a thin layer of ink after 
2 printing layers (Figure 13(n) and (q)) and as printing continued, the sugar 
components were recrystallized to rod-like crystals (Figure 13(o) and (r)). Printing 
on the polymer film substrate (PFS) (Figure 13(s) – (x)) did not appear to make any 
noticeable changes on the smooth surface of this substrate. 
The complimentary EDX analysis was conducted on randomly selected areas on 
the surface of each sample in order to detect chlorine element distribution as an 
indication for presence of propranolol hydrochloride in the printed units. As 
expected, higher amounts of chlorine were consistently detected on areas with 
higher doses with a standard deviation lower than 1.4 w% which was yet another 
confirmation of the uniformity of the printing job (results in publication IV).  
5.3 Content uniformity of inkjet printed formulations (II–V) 
The drug deposited amounts on different substrates as the result of inkjet printing 
techniques were measured by UV spectroscopic (II–V) and HPLC (V) techniques.   
The results for paper (II) showed that the average amount of propranolol deposited 
by the Dimatix piezoelectric inkjet printer on a 1cm2 area was 0.503 ± 0.003 mg, which 
was in close alignment with the expected theoretical value of 0.501 mg. Also, the 
amount of riboflavin in a printed square was found to be 0.340 ± 0.002 mg, which was 
slightly higher than the estimated theoretical value of 0.315 mg. The higher deposition 
of riboflavin ink was attributed to its 50% lower viscosity compared to propranolol ink, 
since the surface tension values of both inks were nearly identical.  
For paper (III), anhydrous theophylline was printed using a thermal inkjet 
printer on 1 cm2 areas of an uncoated copying paper in an escalating system of 1–32 
printing layers. The results showed that the average drug amount of 7.53 ± 0.37 μg 
was achieved for each printed layer. Additionally, an accurate escalating dose 
window of 7.44–246.83 μg was tailored in which the drug dose was directly 
proportional to the number of printed layers with excellent fit accuracy of R2 = 
0.9998 (Figure 14 (a)).  
For paper (IV), propranolol hydrochloride was printed with a thermal inkjet 
printer on 3 different edible substrates and on 3 different area sizes of 1, 2 and 4 cm2 
on each substrate in escalating systems of 2–16 printing layers. The results showed 
that the average drug amount of 49.78 ± 0.01 μg per layer per 1 cm2 area was 
achieved. The dose in all the printed units was directly proportional to the number 
of printed layers and the printed area with the fit accuracy in the range of R2 = 
0.993–0.999 (Figure 14 (b)). 
For paper (V), prednisolone and levothyroxine sodium pentahydrate were 
printed on 2 different edible substrates in an escalating manner that was based on an 
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escalating print resolutions system (500 × 500 to 1000 × 1000 dpi) by the 
piezoelectric inkjet printer. The amount of drug load on substrates was once again in 
good agreement (R2 ≥ 0.997) with the increase in the print resolution (Figure 14 (c)). 
 
Figure 14. The dose flexibility of the printed formulations. (a) Theophylline (III); (b) 
propranolol (IV) and (c) prednisolone and levothyroxine (V). 
In summary, thermal and piezoelectric inkjet printing techniques were able to 
accurately deposit different drugs on various substrates in μg range. The deposited 
drug amount depends on the concentration of the drug in the ink solution, the size 
of the printed area and the viscosity and the surface tension of the ink as well as the 
printing parameters. The extremely high accuracy (R2 = 0.9998) of the drug amount 
with respect to the number of printed layers on uncoated copying paper (III) was 
related to the enhanced printing qualities of such substrate which could greatly 
absorb and retain the drug in ink solution. The usual ‘smearing effect’ of the printed 
ink when using a contact thermal inkjet printer with mechanical handling of the feed 
paper, was not observed for this substrate because of its excellent qualities and 
specific design for printing. Moreover, the non-contact piezoelectric inkjet printing 
(V) technique resulted in a very accurate and uniform deposition of prednisolone 
with respect to the print resolution (R2 = 0.9994). 
5.4 Dissolution studies (I, II) 
For paper (I), the dissolution profiles of 2 APIs, propranolol hydrochloride and 
lidocaine hydrochloride, from different drug-polymer systems were measured by the 
potentiometric method to study the effect of composition and the type of 
formulation in the drug release behavior. Two different polymers, EC and HPC, with 
a substantial difference in aqueous solubility were used with different mass ratios of 
(1:0, 1:1 and 0:1) to produce two types of delivery systems including polymer films 
and porous substrates. The dissolution profiles of the formulations showed major 
differences in drug release kinetics according to the composition and the type of the 
formulations (Figure 15).  
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Figure 15. Drug release profiles of all the formulations measured by the potentiometric 
technique (I). Data are presented as mean ± standard deviation (n = 3). 
The most noticeable feature in the release profiles was the fact that, as the 
concentration of EC increased, the drug release rate decreased accordingly for all the 
formulations with the most drastic results in case of 100% EC (Figure 15 (a) – (c)). 
The drug release was almost immediate in the absence of EC in the formulations. 
More than 80% of the drug was released in the first 20 min which resulted from high 
aqueous solubility and swelling of HPC in the dissolution medium (Figure 15 (a)). 
Also, the drug release from the porous cellulose substrate was much faster than the 
film formulations in each case. This was due to the more porous nature of this 
substrate, its larger surface area (Ø 28 mm compared to Ø 20 mm for the films) and 
the fact that the substrate structure prevented the complete formation of a polymer 
matrix which governed the release. The drug release from the film formulations was 
very similar for both drugs with the same concentration (20 w%) in identical 
polymer ratios (Figure 15 (a) – (c)). As the lidocaine concentration was raised from 
20 w% to 40 w% in the drug-polymer blend, the drug release rates were also 
increased especially in case of 100% EC where the drug release was significantly 
faster (Figure 15 (c)). This great difference in drug release profiles could be related 
to the inability of EC without the HPC to entirely form a non-diffusible layer to 
control the drug release in case of 40 w% of the drug in the drug-polymer system.  
For paper (II), the dissolution profiles of 2 APIs, propranolol hydrochloride and 
riboflavin sodium phosphate, from different formulations that were printed on 4 
different substrates with multiple polymer coating (5 and 30 layers) were studied. 
The printed formulations were coated on both sides with a water impermeable 
polymeric membrane consisted of EC:ethanol (5:95 w%) using flexographic printing 
in order to investigate the effect of such polymer coatings on the drug release 
profiles. The thickness of each coating layer was calculated to be between 100 and 
200 nm. The extensive dissolution results are presented in Figure 16.  
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Figure 16. Drug release profiles of propranolol hydrochloride (a–c) and riboflavin 
sodium phosphate (d–f) printed on different substrates: (a) and (d) without any 
coating; (b) and (e) after five layers of EC coating and coating (c) and (f) after 30 
layers of EC coating (II). Data are presented as mean ± standard deviation (n = 3). 
Propranolol was almost completely released from all the uncoated formulations in 
the first 10 min (Figure 16(a)). Propranolol release from substrate ‘B’ was slightly 
affected in the early stages after EC coating; however, the drug release from the other 
substrates was not affected significantly after coating (Figure 16(b) and (c)). The 
riboflavin sodium phosphate release was observed to be slower than propranolol for 
each case. Both sides of substrate ‘A’ showed nearly identical release profiles for both 
drugs. The riboflavin release was generally more affected especially for substrates ‘B’ 
and ‘C’ after coating (Figure 16 (d) – (f)). The drug release from substrate ‘B’ was 
found to be the slowest which was followed by substrate ‘C’. These two substrates 
were found to be better candidates for manufacturing controlled-release printed 
formulations coated by EC. The results showed the effect of the water impermeable 
coating together with the nature of substrates on the release of both APIs as the 
number of coating layers increased (Figure 16(b), (c), (e) and (f)).  
According to Ozturk et al. (1990), the drug release through EC coated layers is a 
function of the thickness and the integrity of the coating material since diffusion 
through the film coating has been considered as one of the main driving forces for 
drug dissolution. The difference in the release behavior between the APIs was 
related to different solubility values of the APIs in ethanol which was used as the 
solvent in the coating polymer solution. Propranolol hydrochloride is soluble in 
ethanol but riboflavin sodium phosphate has poor solubility in ethanol (European 
pharmacopoeia, 2011). For this reason, it was speculated that propranolol could 
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partially dissolve and migrate into the forming polymeric layer during flexographic 
printing which later resulted in higher diffusion and subsequently higher 
dissolution rate of the drug from the formulations in the presence of the acidic 
dissolution medium. Swelling of the fibers of the substrates in contact with 
aqueous medium according to the nature, surface roughness and topography of 
these substrates could also cause partial detachment from polymeric coating layers 
and further explain the release behavior of the APIs from the substrates. Also, after 
cutting of each dosage form into single units, the sides of the edges were left 
exposed without coating which could be a helping factor for penetration of the 
dissolution media and eventually speeding up the dissolution process. It must be 
noted that the very thin layer of the coating which was less than 6 μm for 30 
coating layers together with the abovementioned factors, resulted in faster drug 
release than reported by Ozturk et al. (1990) in which the EC coatings thickness 
varied between 9 and 50 μm.  
In summary, it was confirmed that the presence of non-soluble EC polymer both 
within the formulations and as a coating layer could significantly govern the drug 
release of the printed and solvent-casted formulations. 
5.5 Disintegration time and texture analysis (IV–V) 
During disintegration studies for paper (IV), immediate swelling was observed for 
both ERP and CERP substrates when introduced to the aqueous medium (Phosphate 
buffer pH6). The disintegration mechanism of EIS was seen to be governed by the 
erosion of the particles from the surface of the substrate. The disintegration results 
are presented in Table 1. EPR showed the fastest disintegration time. The added 
HPC layer on CERP extended the disintegration time of this substrate more than 
twice as compared to ERP. The data clearly showed the influence of the clip weight 
in decreasing the disintegration time. However, as the clip weight increased, the 
change in disintegration time of EIS was not as considerable as it was for the other 
two substrates since its disintegration was governed by erosion. In conclusion, the 
disintegration time results were all within the defined 180 s (Ph.Eur.). 
Table 1. Disintegration time (s) of the substrates using different weights (g). Data are 
presented as mean ± standard deviation (n = 10). 
Clip weight (g) ERP CERP EIS 
3 20.04±1.99 43.58±5.24 69.34±5.21 
5 11.99±1.52 36.86±4.43 64.10±5.62 
 
The texture analysis and the disintegration results of the blank and the printed 
substrates for paper (V) are presented in Table 2. The disintegration times were well 
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within the limit of 180 s for both substrates before and after printing, even though the 
exerted force of 0.01 N (1 g clip weight) was lower than the approximate minimal force 
applied by the human tongue (0.03 N) (Hermes, 2012). PFS disintegrated much faster 
than EIS when introduced to the aqueous medium. Also, printing had only a slight 
effect to lower the disintegration time of both substrates. 
Table 2. Texture properties and disintegration values of the raw and the printed 
substrates. Data are presented as mean ± standard deviation (n = 10). 
 Tensile 
strength (N/mm2) 
Puncture 
resistance (kPa) 
Distance at 
burst (mm) 
Elongation
% 
Disintegration 
time (s) 
Blank EIS 0.59±0.16 15.28±3.99 1.39±0.09 4.44±0.45 72.48±2.88 
700 dpi on EIS 0.23±0.03 12.00±1.16 1.41±0.19 5.46±1.01 71.68±3.16 
1000 dpi on EIS 0.17±0.04 8.97±0.47 1.35±0.2 5.25±0.94 71.56±3.28 
Blank PFS 3.21±0.17 45.20±4.74 1.67±0.21 7.02±1.32 8.57±1.15 
700 dpi on PFS 1.36±0.32 25.08±4.67 1.53±0.18 5.94±1.1 8.21±1.44 
1000 dpi on PFS 1.69±0.21 19.83±4.46 1.18±0.24 5.85±0.85 7.58±1.75 
In conclusion, as compared to the printed formulations, the blank substrates 
showed higher mechanical resistance towards the potential physical damage in the 
production line. This was more evident for PFS that was produced as a thin film 
manually. The disintegration time was reduced as the printing resolution increased; 
however, not significantly. 
5.6 SC-ISEs and potentiometric technique (I) 
For paper (I), the performance of the ion-selective electrodes that were designed and 
conditioned to be selective for propranolol hydrochloride was validated by 
comparison of the drug release profiles between the two methods of UV 
spectroscopy and potentiometry (Figure 17).  
 
Figure 17. Comparison of ion-selective electrodes (ISEs) to UV spectrophotometry in 
measurement of the drug release from the drop-casted film formulations (n = 3). 
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The data showed almost identical drug release profiles in all formulations for both 
methods except in case of porous substrate in presence of only EC (Figure 17 (c)). In 
this case, after an hour mark a noticeable difference (<12% release) between the two 
profiles was observed. This difference was speculated to be the result of the 
interaction of the released protonated propranolol molecules with the components 
of the cellulose substrate in the solution. As a result of this, a less free protonated 
form of propranolol (lower activity of Pr+) was available to be detected by the 
electrodes.  
The calibration plots of the electrodes revealed the lower detection limit and the 
deviation from the ideal value of 59.16 mV in the slope of the curves for every 
10−fold decrease in the concentration (cycle) of the APIs in the medium. The lower 
detection limit and the slope of the curves were found to be 0.92 μg/ml and 57.8 mV 
for propranolol selective electrodes and 0.54 μg/ml and 57.1 mV for lidocaine 
selective electrodes. Such values were considered quite satisfactory given the fact that 
the ideal slope for the working range of the ISEs is 59.16 mV per cycle. In addition, 
comparison of the lower detection limits of the propranolol electrodes to the UV 
spectroscopic instrument revealed a slightly lower detection limit for the electrodes 
(0.92 μg/ml) as the absorbance read value from a solution with the concentration of 
1 μg/ml was already deviated from the linear relationship with the higher 
concentrations of the drug.    
In conclusion, the ISEs showed promise as a fast-responding, inexpensive, 
accurate and reliable alternative for the study of the drug release from various 
formulations. In addition, potentiometric measurement was capable of collecting 
data in only a few seconds increment that resulted in more continuous monitoring 
of the drug release compared to the UV method. Further investigations were carried 
out to study the quality and working conditions of the electrodes. 
5.7 Hyperspectral NIR imaging technique (III) 
For paper (III), the entire escalating printed system was scanned by a hyperspectral 
imaging instrument. The spectral information was collected from each pixel in the 
field of view and then with the help of multivariate analysis was translated into the 
final concentration maps for readings of the API content from any desirable area. 
The PCA revealed that PC1 and PC2 explained 59.0% and 6.9% of the variations in 
the spectral data, respectively. In addition, the loading profile (Figure 18) of the first 
two principal components showed the most influential wavelength on the overall 
form of the scores plot. It is well known that variables with further distance from the 
neutral axis on the loading plot have a stronger impact on the model in opposite 
directions when situated above or below the neutral axis. Therefore, it was 
concluded that the spectral data related to the specific wavelengths of 1940 nm, 
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defined by PC1, were responsible for explaining the most relevant variation in the 
entire data cloud. 
 
Figure 18. The loading plots of the first and the second principal components. 
The pseudocolor RGB score image of the printed system (Figure 19(a)) was then 
generated in which PC1 was coded as red and PC2 was coded as green. Figure 19(a) 
presents a spatial map that associates the spectral signatures to colors in RGB color 
space in order to distinguish regions with similar and contrasting chemical 
compositions. The number of printed layers and, therefore, the amount of deposited 
API increased continuously from the top left square unit to the bottom right one as it 
was also displayed in the pseudocolor RGB score image. Similarly, the PCA contour 
2D plot (Figure 19(b)) was created to demonstrate the spatial displacement of 
individual pixels according to their chemical composition. Each pixel was color coded 
in a continuum changing from cold (blue) to warm (red). It was evident that the 
increase in API content was in agreement with the shift from blue to red color. The 
score plot (Figure 19(c)) which used the same color coding system represents the 
relationships between observations on a new coordinate system defined by the first 
two principal components. 
Figure 19. Plots of hyperspectral imaging. (a) RGB image of the original set of 
formulations; (b) the PCA contour 2D plot and (c) the score plot.  
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From an analytical point of view, the possibility of observing such detailed visual 
information that could be directly correlated to the drug amount is the indication of 
the great functionality of hyperspectral NIR imaging technique in quality control of 
the printed dosage forms.  
Finally, the plot of predicted vs. measured API content is presented in Figure 20. 
The predicted values for samples with lower API content had greater error due to the 
interference of the substrate signal. Overall, the good correlation (R2 = 0.974) 
between the predicted and measured values showed the high power of the created 
model for estimation of the drug amount in the formulations. 
 
Figure 20. The plot of predicted vs. measured API content.  
5.8 Colorimetric technique (IV) 
In experiments related to paper (IV), the propranolol contained ink solution was 
naturally colorless. Therefore, for the purpose of conducting a colorimetric 
measurement it was required to add a coloring agent to the ink solution before 
printing. The assumption was made knowing that as long as both the API and the 
coloring agent were dissolved in a clear solution, their respective amounts would be 
identical in any portion of the ink solution. Thus, by measuring the color differences 
between the surface of the printed formulations and the reference surface, one could 
estimate the API amount indirectly. If that assumption were to be correct, then there 
would be a meaningful correlation between the colorimetric coefficients of the 
printed formulations and the number of printed layers. It is understood that the dose 
escalation in an inkjet printed system is always in great agreement with the number 
of printed layers. It should be noted that the comparison of ATR-IR spectra of the 
colored and non-colored API contained ink confirmed no chemical interactions 
between the coloring agent and the drug-excipients systems, which further justified 
the validity of the colorimetric measurements. 
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The colorimetric studies were performed in the CIELAB color space (Figure 
21(a)). According to Eq. 3, it is known that each obtained numerical value of 
(ΔE*ab) is in fact the distance from the reference point in 3D CIELAB space. Figure 
(21(b) – (d)) represent the 3D spatial location of (ΔE*ab) values of each individual 
printed unit on each substrate as a series of single data points on the chromaticity 
plots (the plane of a* and b*) with their corresponding lightness/intensity component 
(L* axis) that was marked with the green lines. The total number of 3 substrates were 
used for this project and they were named as follows: edible rice paper (ERP), coated 
edible rice paper (CERP) and edible icing sheet (EIS).  
A clear distinction between the color coordinates of the formulations was 
observed. For better visual understanding, one unit from each substrate (1 layer 
printed on ERP, 8 layers on CERP and 16 layers on EIS) was selected and their 
colorimetric components were highlighted in blue color (Figure 21(b) – (d)). As the 
number of printing layers increased, a systemic shift towards the red side of the 
chromatograms (right side) as well as an increase in the color intensity component 
were observed. This observation was confirmed for all the formulations, which 
further demonstrated the meaningful classification power of the applied colorimetric 
device. 
 
Figure 21. (a) The CIELAB colorimetric system representing the numerical parameters 
a*, b* and L*; (b) chromaticity plot, lightness plot and generated color group of 2-16 
layers of printed formulations on ERP substrate; (c) on CERP substrate and (d) on EIS 
substrate. 
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Eventually, the validation of the colorimetric technique was accomplished by 
plotting (ΔE*ab) values against the drug amount (mg) (Figure 22).  
 
Figure 22. Plots of colorimetric values ΔE*ab against the drug amount (mg) on 3 
different substrates. (a) ERP; (b) CERP and (c) EIS. 
The fit accuracy (R2) of the linear relationship between the ΔE*ab values and the 
drug amount was found to be 0.993, 0.986 and 0.979 for ERP, CERP and EIS, 
respectively. The printing ink penetrated deeper inside the highly porous structure 
of ERP matrix and this resulted in more accurate color reading from the printed area 
with less deviation from the linearity compared to the other substrates. The shearing 
forces applied on the previously printed areas by the feeding rollers with the paper 
face-down feeding system affected the color uniformity of the less permeable and 
less absorptive EIS and CERP substrates. This is known as the smearing effect. As a 
result of this, there were more stained marks on these two substrates that were 
visible to the naked eye and possibly influenced the results. 
The quality of the colorimetric technique was evident in the final results for all 
the substrates. It must be noted that the color difference values recorded in this 
study were due to the presence of the coloring agent in the ink solution and not the 
colorless drug. However, due to the linear relationship between the number of 
printed layers and the drug amount, as shown earlier in (Figure 14(b)), the color 
difference values could also be correlated to the drug content. The color of many 
inherently colorless drug containing ink solutions can be easily modified by the 
addition of inert coloring agents exclusively for the purpose of conducting 
colorimetric measurements. The applied colorimetric technique can be successfully 
calibrated and used as a fast and non-invasive quality control method for printed 
formulations. The presented approach is widely transferable when dealing with APIs 
that are freely soluble in the solvent with no risk of precipitation or degradation. 
Further investigation was carried out by ATR-IR spectroscopy to ensure that there 
was no chemical interaction between the drug and the excipients that could affect 
the results (reference to paper IV). 
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5.9 NIR measurements (V) 
5.9.1 Model analysis 
For paper (V), PCA and OPLS methods were performed on the collected spectra 
from dose escalating printed systems containing prednisolone and levothyroxine 
sodium in the range of 1550–1950 nm. The modelling parameters were obtained by 
cross–validation of the data in 7 groups as default (Table 3).  
 
Table 3. Summary of predictive models created by OPLS method. 
Model PCa Filter summary Q2 
(cum) 
R2Y 
(cum) 
R2x 
(predictive) 
R2x 
(cum) 
RMSEcv 
(mg) 
RMSEE 
(mg) 
Prednisolone on EIS 1+1 Ctr-SG-3rd der 0.982 0.983 0.944 0.995 0.069 0.069 
Prednisolone on PFS 1+1 Ctr-SG-3rd der 0.988 0.99 0.944 0.996 0.056 0.054 
Levothyroxine on EIS 1+2 Ctr-SG-3rd der 0.958 0.962 0.926 0.995 0.051 0.050 
Levothyroxine on PFS 1+2 Ctr-SG-3rd der 0.941 0.948 0.874 0.992 0.061 0.060 
aR2x (predictive) + number of R2xo (orthogonal).  
The predictive ability (Q2 (cum)) of the models was found to be in the range of 
0.941−0.988 and the goodness of fit values (R2Y (cum)) were in the range of 
0.948−0.990. R2x (predictive) values were between 87.4% and 94.4%, showing how 
well PC1 could explain the variation in the data cloud in its direction. Furthermore, it 
could be seen that more than 99.2% of the variance in the X matrix was explained in 
all models with only 2 or 3 PCs indicating the low complexity of the datasets. Root 
mean square error of cross–validation (RMSEcv) and root mean square error of 
estimation (RMSEE) for the models show that only about 5% of the predicted 
concentration values would have an error of estimation more than ±0.07 mg in all 
the models. 
5.9.2 Classification of observations 
The OPLS scatter score plots of the models are illustrated in Figure 23. Scatter score 
plots are the projection of the multidimensional data cloud on the 2D plane with a 
new system of coordination (PCs) for better understanding and interpretation of the 
variations in the original datasets. The spectra of each single printed dosage form 
were translated into a single observation point on the score plot to disclose the 
interrelationship between the observations in each model. The plots indicated that 
the data carry class separating information and the OPLS methods were able to 
separate different classes of each model. The classification of the observations was 
more powerful for prednisolone models (Figure 23(a) and (b)) in which no 
considerable overlap between neighboring class regions was observed as compared 
to levothyroxine models (Figure 23(c) and (d)).  
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The separation of classes in the t[1] direction demonstrated the variation between 
classes. The variation in this direction was the most important as R2X [1] values 
revealed that between 87.4% and 94.4% of all the variations in each data clouds were 
in the direction of the first principal component. In other words, only one vector 
(PC1) passing through the data cloud in each model could explain the most 
significant portion of all the variations in its direction. This finding was clearly in 
agreement with the design of experiment (DoE) in which the amount of deposited 
drug was the only factor defining the differences between the formulations. 
However, the separation in the to[1] direction was corresponding to the variations 
within classes which were caused mainly by the baseline shift in the spectra. The first 
orthogonal vector (R2Xo[1]) in each model was only responsible for explaining 
between 4.40% and 8.35% of the remaining variations. This indicated the 
insignificance of the variations in this direction as compared to the R2X [1] direction. 
Thus, the to[1] axis mostly served to generate and display the score plots in two-
dimensions.  
 
Figure 23. Score scatter plots of the OPLS models scaled proportionally to R2X. (a) 
prednisolone on EIS; (b) prednisolone on PFS; (c) levothyroxine on EIS and (d) 
levothyroxine on PFS. The observations are colored according to their respective drug 
amount.  
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5.9.3. Predictions 
The validation plots of the predictive models are presented in Figure 24.  
 
Figure 24. The validation plots of the predictive models according to the print 
resolutions (dpi index) for both drugs. (n=10 for EIS and n=5 for PFS). The 100% line 
marks the actual drug amount that was measured by the reference analytical methods. 
The error of prediction was higher for the lowest doses, mainly due to the 
undesired effects of the spectral signals arising from the substrates (high noise-to-
signal ratio). Since the prednisolone models had higher predicting power (Table 1), 
they showed more accurate predictive qualities with lower standard deviations. The 
error variance (R2) of the observed vs. predicted for prednisolone content was found 
to be 0.991 on EIS and 0.997 on PFS and for levothyroxine content R2 was 0.952 on 
EIS and 0.968 on PFS when the highly erratic predictions of the lowest doses were 
not included.  
In conclusion, such results show promise in applicability of the handheld NIR 
probe for on-site prediction of drug content of the printed formulations in a non–
invasive fashion at the point of care. 
5.10. DSC (IV–V) 
Propranolol hydrochloride can exist in three crystalline forms, which are denoted as 
form I, II and III according to their decreasing melting points (Bartolomei et al., 
1998). The DSC thermogram of the pure drug in Figure 25 (a) showed a sharp 
endothermic peak at 164.28 °C with heat of fusion (ΔHf) of 134.2 J/g and onset 
temperature at 161.96 °C representing the melting point of the commercially 
available polymorph II of propranolol hydrochloride. The DSC thermogram of the 
freshly printed formulations did not feature any thermal events (Figure 25(b), (c) 
and (d)). After 3 months of storage time, thermograms of ERP and CERP 
formulations revealed weak endothermic thermal events with onset temperatures at 
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152.02 ˚C (ΔHf = 7.55 J/g) and 144.33 ˚C (ΔHf = 2.24 J/g), respectively (Figure 25(e) 
and (f)). These thermal events were indicative of a partial recrystallization of the 
drug in time. The onset temperatures of these melting peaks were shifted to lower 
temperatures due to the interactions of the drug with the potato starch. The presence 
of HPC polymer on CERP seemed to fairly reduce such interactions between the 
drug and the potato starch underneath. There was also no thermal event observed 
for the stored EIS formulations (Figure 25(g)) much like all the fresh formulations 
which further indicated that the drug was molecularly dispersed within the substrate 
matrix. 
 
Figure 25. DSC thermograms of (a) pure propranolol hydrochloride; (b) 16 layers on 
ERP; (c) 16 layers on CERP; (d) 16 layers on EIS; (e) 16 layers on ERP after 3 months; 
(f) 16 layers on CERP after 3 months and (g) 16 layers on EIS after 3 months. 
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6. Conclusions 
This thesis presents the very first step as comprehensive research with the focus on 
exploring the potential of various analytical techniques in quality control of printed 
pharmaceutical dosage forms. Performance of a series of compact, cost-effective and 
non-destructive analytical methods was investigated for real time monitoring of 
drug content uniformity and drug release profiles of printed formulation to provide 
further research advancements towards the goal of ultimate adoption and regulation 
of such techniques in the pharmaceutical industry. Various inkjet printing 
technologies were used to successfully manufacture dose flexible drug delivery 
systems in microgram precision. The printed formulations contained a variety of 
poorly water soluble drugs, narrow therapeutic index drugs and drugs that were 
prone to first-pass metabolism. Dose flexibility was achieved either by printing 
several superimposed layers or by changing the print resolution to adjust the 
number of drops in a defined area size. The drug amounts on printed formulations 
have repeatedly proved to be highly linear with respect to escalation of printing 
layers or resolution. Therefore, in agreement with many publications on the subject, 
it was concluded that inkjet printing was an extremely accurate method for rapid 
and on-demand deposition of various APIs on planar substrates. Also, the control 
over the drug release profiles of the manufactured formulations was effectively 
accomplished either by addition of the polymers directly with the drug in the 
formulation design or by several layers of additional polymeric coating on already 
printed formulations by flexographic printing or manually with a coating knife.  
In the future, when inkjet printing is eventually authorized for printing 
pharmaceuticals, there will be a demand for production of specific inkjet printers 
with simpler, more affordable and more compact design using disposable units to 
help resolving practical issues such as cleaning of tubing and the printhead after each 
printing job in order to avoid clogging, contamination and waste of time and 
materials. 
The surface morphology and visual microscopy were also conducted in various 
studies to gain a deeper understanding about the effect of printing on the substrate 
and the physical changes in microscopic levels. The solid-state properties of the 
formulations were examined using differential scanning calorimetry and attenuated 
total reflection infrared which revealed that in many cases the drugs were 
molecularly dispersed within the porous structure of the substrates as no significant 
chemical reaction between the drug and excipient was recorded. Additional 
mechanical, texture and disintegration analyses were carried out to ensure the 
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physical properties of the orodispersible formulations within the latest framework 
defined by Ph. Eur. 
Ion-selective electrodes that were designed to be responsive for two drugs showed 
good quality under various conditions and were able to reliably measure the drug 
release in steps of a few seconds from porous cellulose matrices. NIR hyperspectral 
imaging was used to predict the drug amount and to create highly informative 
concentration distribution maps of the drug in printed formulations in a non-
destructive manner. The application of a handheld colorimetric device in CIELAB 
color space showed promise in the assessment of the drug content simply by 
measuring the color difference values of the dose escalating system of formulations. 
Such encouraging results of the colorimetric technique suggested a broad range of 
possibilities for addition of inert coloring agents to various colorless ink solution and 
the subsequent indirect estimation of the drug in the printed formulations. Finally, a 
compact handheld probe was used to collect the NIR spectra from the surface of the 
printed formulations. The spectra were subsequently treated using sophisticated 
chemometrics for interpretation of the multivariate data and building the predictive 
models. This NIR device has never been used in pharmaceutical research before and 
it proved to have the potential for in-line, non-invasive and reliable quality control 
of the printed formulations at the envisaged point of care manufacturing scenario. 
In the end, additional research is necessary to focus on many remaining issues 
such as the interaction of various drug candidates with many possible printing inks 
and substrates, the effect of drug degradation and solid-state transformation in 
presence of various excipients for each scenario, the stability of the drug in the 
printing ink, the effective removal of the organic ink solvents from the printed 
formulations, finding optimal printing parameters suitable for different inks and 
printers, deeper understanding of the possible sources of error and interference in 
each analytical practice and further exercise on handling the chemometrics to 
maximize the useful information in the obtained multivariate data.  
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7. Sammanfattning (Summary in Swedish) 
Det finns ett behov av utveckling och produktion av farmaceutiska dosformer med 
flexibel dosering för att uppnå de centrala kraven för precisionsmedicin för 
patientspecifik terapi. Precisionsmedicin innebär ett paradigmskifte i klinisk praxis, 
personifierad diagnostisering av sjukdomen, individuell formuleringsdesign och 
tillverkning av skräddarsydda doseringsformer för att åstadkomma en optimal och 
väl tolererad terapeutisk behandling. 
Nya teknologier möjliggör vid behov tillverkning av små läkemedelssatser med 
dosflexibilitet. Detta är viktigt i framställning av skräddarsydda läkemedel nära 
patienten, till exempel i sjukhus eller på apotek. I detta avseende har 
bläckstråleutskriftsteknik föreslagits under det senaste decenniet som en metod att 
deponera extremt noggranna och små mängder läkemedel på olika ätbara 
polymerfilmer. Dagens bläckstråleskrivare med kompakt design, öppen arkitektur 
och avancerade integrerade visualiseringssystem erbjuder noggrann kontroll över 
storleken och placeringen av de tusentals enskilda bläckdropparna i picolitervolym. 
Utskrivna läkemedel formuleras ofta på ett sätt att de upplöses snabbt i munnen 
vilket underlättar administrering och ger en högre följsamhet av behandlingen, 
speciellt för barn och personer med sväljningssvårigheter. Ifall läkemedlet absorberas 
genom munslemhinnan direkt till den systemiska cirkulation kan 
förstapassagemetabolismen i levern också undvikas vilket kan leda till en snabbare 
terapeutisk effekt.  
En av de viktigaste aspekterna för att tillsynsmyndigheterna ska acceptera 
bläckstråleskrivning som en allmänt accepterad metod för kontinuerlig tillverkning, 
krävs snabba, robusta, pålitliga och icke-invasiva analytiska metoder för 
kvalitetskontroll. Denna avhandling var huvudsakligen inriktad på att utforska olika 
analytiska metoder och småskaliga instrument för att studera doseringsnoggranhet 
och läkemedelsfrisättning i de tryckta läkemedelsformuleringarna. 
Jonselektiva elektroder konstruerades för kontinuerlig övervakning av 
läkemedelsfrisättningen från porösa cellulosasubstrat och tunna filmer som ett 
försök att föreslå ett kostnadseffektivt och effektivt alternativ till konventionella tids- 
och arbetskrävande metoder. Flexografisk tryckteknik utnyttjades för att applicera 
flera lager av högviskös och olöslig polymerbeläggning på redan bläckstråleskrivna 
formuleringar för att uppnå formuleringar med modifierade frisättningsprofiler. 
Närainfraröd hyperspektral bildbehandling tillämpades för att förutsäga 
läkemedelsmängden och att skapa koncentrationsfördelningskartor som erbjuder 
både statistiska och visuella bedömningar av de tryckta formuleringarna. 
Användningen av en kompakt kolorimetrisk apparat undersöktes (i CIELAB 
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färgutrymme) för att uppskatta läkemedelsinnehållet i pediatriska 
munsönderfallande formuleringar. Slutligen användes en NIR-spektrometer i 
miniatyrform tillsammans med avancerade kemometriska metoder för att bygga 
prediktiva modeller för att analysera läkemedelsinnehållet i doseringsformerna. 
Dessutom behandlas tillämpningen av multivariata dataanalysstekniker för 
bearbetning och modellering av spektroskopiska data i detalj. Flera andra analytiska 
tekniker användes även för att studera ytmorfologi, ythårdhet, ytstruktur, mekaniska 
egenskaper och fasta fasens egenskaper hos de obehandlade och tryckta substraten 
samt stabiliteten av formuleringarna. Fördelarna och bristerna av varje 
formuleringsdesign och tillämpad analysmetod lyfts fram och en allmän strategi för 
framtida studier föreslås. 
Denna forskning ger en djupare inblick i bläckstråleskrivningsprocessen för 
läkemedelsformuleringar och ger ny förståelse om användbarheten av olika icke-
invasiva kvalitetskontrollsverktyg i tillverkning av personifierade läkemedelsformer.
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A Summary in Swedish
Vissa patientgrupper, t.ex. barn, behöver en mycket specifik dos av ett 
läkemedel för att nå en optimal terapeutiskt effekt. Därför behöver 
läkemedelsdosen i läkemedlet justeras specifikt för patienten. I den 
här avhandlingen undersöktes hur utskriftsteknologier kan användas 
i dosering av läkemedel och kombineras med lämpliga kvalitetskon-
trollsmetoder. Bläckstråleskrivarteknik erbjuder en lösning för att pro-
ducera sådana precisionsmediciner. Läkemedlet löses i ett lämpligt 
lösningsmedel och hälls i bläckpatronen i en skrivare. Därefter pro-
duceras läkemedlet genom tryckning på ätbara substrat eller filmer. 
Läkemedelsdosen kan justeras med hög noggrannhet och reproduc-
erbarhet på dessa tunna, stämpellika läkemedel som placeras i mun-
nen och löses upp snabbt.  Produktionshastigheten för dessa läkeme-
del är högt och tillverkningen behöver därför kombineras med snabba 
men pålitliga analysmetoder för kvalitetskontroll.
I optimala fall kunde denna småskaliga teknologi användas som en 
produktionslinje inom läkemdelsindustrin eller på apoteket där läkem-
edlet kunde tryckas direkt för patienten. Kvalitetskontrollmetoderna 
som undersöktes baserar sig bl.a. på spektroskopi och kolorimetri med 
vilka man mäter intensiteten av det reflekterade ljuset eller färgen från 
ytan av de utskrivna läkemedlen utan att röra provet. På så sätt förstör 
inte den använda metoden läkemedlet när den analyseras. Förändrin-
garna i ljus- och färgintensiteten kan relateras till läkemedelsmängden 
och dess fysikaliska egenskaper. I avhandlingen undersöktes fördelar-
na och nackdelarna av de olika analytiska metoderna. Arbete visar ty-
dligt att utskrifteknologier som används i kombination med lämpliga 
kvalitetskontrollsmetoder har stor potential att möjliggöra personalis-
erad dosering av läkemedel i framtiden.
A tailor-made dose suits you best.
